https://www.dailyhealthindustry.it/novartis-investira-nella-tecnologia-mrna/ 2021-07-01T08:46:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-nel-marketing-e-il-momento-dellomnicanalita/ 2021-07-01T13:13:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-vaccino-covid-protegge-a-lungo-contro-linfezione/ 2021-07-02T08:33:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/public-health-england-vaccino-astrazeneca-efficace-al-94-nel-prevenire-le-morti-negli-over-65/ 2021-07-02T08:44:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-curevac-colloqui-con-ue-su-eventuale-distribuzione-vaccino/ 2021-07-02T09:01:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-usa-squadre-speciali-in-zone-critiche-per-contrastare-la-diffusione-della-variante-delta/ 2021-07-02T09:15:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-e-alector-partnership-da-2-mld-di-dollari-per-sviluppare-farmaci-contro-le-malattie-neurodegenerative/ 2021-07-05T08:36:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/flavio-caruso-e-il-nuovo-cfo-di-novartis-italia/ 2021-07-05T09:13:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sifo-un-progetto-per-valutare-lappropriatezza-prescrittiva-delle-terapie-innovative-ad-alto-costo/ 2021-07-05T10:15:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-cristina-zocchetti-nuovo-direttore-medico-e-scientifico-per-italia-e-olanda/ 2021-07-05T12:26:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-fine-chemicals-potenzia-il-sito-di-aprilia/ 2021-07-05T12:43:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-le-ultime-novita-dalleha/ 2021-07-05T14:25:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asma-grave-una-patologia-invisibile-che-va-affrontata-a-livello-nazionale/ 2021-07-06T09:22:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-respinge-richiesta-fondo-elliott-su-cambio-leadership/ 2021-07-06T08:25:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-ema-si-ad-aumento-di-produzione-stabilimento-leida/ 2021-07-06T08:27:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-nejm-con-vaccini-a-mrna-rari-i-casi-di-infezione-anche-con-una-sola-dose/ 2021-07-06T09:09:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-pfizerbiontech-dati-israeliani-a-sei-mesi-efficacia-alta-su-malattia-grave/ 2021-07-06T13:08:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-eli-lilly-da-studio-emperor-preserved-conferme-per-lefficacia-di-empagliflozin-nella-hfpef/ 2021-07-06T13:40:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-terapia-car-t-superiore-a-standard-di-cura-nel-lbcl/ 2021-07-06T15:41:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/loms-raccomanda-farmaci-di-roche-e-di-sanofi-per-ridurre-il-rischio-di-morte-da-covid-19/ 2021-07-07T09:00:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-produrra-in-austria-farmaco-destinato-al-mercato-usa/ 2021-07-07T09:13:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-solo-il-3-dei-pazienti-usa-i-programmi-di-supporto-delle-aziende/ 2021-07-07T14:23:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-e-pfizer-bilancio-del-progetto-vicini-di-salute/ 2021-07-07T12:36:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/phoenix-group-acquisisce-parte-degli-asset-di-mckesson-in-europa/ 2021-07-07T12:56:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-si-prepara-per-le-olimpiadi-pubblicizzando-trulicity-emgality-e-verzenio-con-atleti-del-team-usa/ 2021-07-08T09:11:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-oms-cautela-nel-mettere-fine-alle-restrizioni/ 2021-07-08T09:25:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-gestione-del-rischio-nelle-sale-operatorie/ 2021-07-08T11:00:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-vaccini-e-dpi-il-covid-ha-svelato-i-punti-deboli-degli-approvvigionamenti-in-sanita-il-codice-degli-appalti-e-da-rivedere-puntando-su-qualita-programmazione-e-produzione-interna/ 2021-07-08T12:37:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-via-allo-studio-di-fase-3-destiny-gastric04-per-enhertu-nelladenocarcinoma-dello-stomaco/ 2021-07-08T12:48:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-autorizzazione-per-uso-in-emergenza-cosa-ci-ha-insegnato-la-pandemia/ 2021-07-08T14:30:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-amgen-speedy-review-fda-per-tezepelumab-asma/ 2021-07-09T08:31:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-alla-fda-la-richiesta-di-autorizzare-una-dose-di-richiamo-del-vaccino-covid/ 2021-07-09T08:55:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-fda-restringe-uso-di-aducanumab/ 2021-07-09T10:28:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/agenas-pronto-il-nuovo-statuto/ 2021-07-10T15:54:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dl-sostegni-bis-arriva-il-fondo-unico-per-i-farmaci-innovativi/ 2021-07-10T15:59:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cambia-la-remunerazione-delle-farmacie-in-arrivo-200-milioni-in-piu-per-rafforzare-attivita-di-prossimita-e-per-sostenere-la-vaccinazione-anti-covid/ 2021-07-10T16:06:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-biogen-pfizer-lanciano-un-database-pubblico-sul-collegamento-tra-geni-e-malattie/ 2021-07-12T08:36:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-potenziale-legame-tra-infiammazioni-cardiache-e-vaccini-anti-covid19-basati-su-rna/ 2021-07-12T13:15:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-variante-delta-pfizer-biontech-spingono-per-autorizzazione-terza-dose/ 2021-07-12T13:14:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-stop-a-consegne-di-astrazeneca-e-johnson-johnson-per-almeno-un-mese/ 2021-07-12T13:14:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-fda-chiede-inchiesta-federale-su-approvazione-aducanumab/ 2021-07-12T13:29:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/innovazione-in-sanita-stato-dellarte-e-prospettive-in-italia/ 2021-07-12T14:27:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-gsk-vir-biotechnology-speranza-da-il-via-libera-a-nuovo-anticorpo-monoclonale-sotrovimab/ 2021-07-15T08:08:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-vaccino-pfizerbiontech-efficace-anche-su-persone-sottoposte-a-trapianto-di-cellule-ematopoietiche-o-terapia-car-t/ 2021-07-15T08:25:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-reithera-buoni-risultati-in-fase-intermedia-per-il-vaccino-italiano/ 2021-07-15T08:35:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-pronta-ad-acquistare-candidato-di-prothena-per-oltre-1-mld-di-dollari/ 2021-07-15T08:44:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-variante-delta-completare-il-ciclo-vaccinale/ 2021-07-15T09:05:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-le-terapie-innovative-avanzano-ma-il-sistema-e-ancora-troppo-indietro-le-riflessioni-a-camerae-sanitatis/ 2021-07-15T09:15:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nejm-vaccino-johnson-johnson-mostra-risposta-immunitaria-duratura/ 2021-07-15T12:37:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-roche-al-via-la-nuova-edizione-del-bando-fondazione-roche-per-i-pazienti/ 2021-07-15T14:05:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk-quale-futuro-per-il-management-e-per-la-sanita/ 2021-07-16T08:22:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizerbiontech-efficacia-vaccino-nella-popolazione-ibd-paragonabile-a-quella-nella-popolazione-generale/ 2021-07-16T08:41:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-a-mrna-nuove-evidenze-dal-mondo-reale/ 2021-07-16T08:45:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-gilead-studio-italiano-remdesivir-sicuro-nonostante-il-rischio-di-bradicardia/ 2021-07-16T12:38:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-oms-no-alluso-della-certificazione-vaccinale-per-viaggi-internazionali/ 2021-07-16T12:52:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-buoni-risultati-per-daprodustat-nellanemia-da-malattie-renali/ 2021-07-19T09:39:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-chi-guida-la-classifica-delle-approvazioni/ 2021-07-19T10:21:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-da-aifa-nuove-avvertenze-per-rischi-molto-rari-su-vaccini-janssen-pfizer-e-moderna/ 2021-07-19T12:16:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-vaccino-astrazeneca-efficace-e-sicuro-anche-tra-persone-con-infezione-da-hiv/ 2021-07-19T14:53:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-550-milioni-di-dollari-per-costruire-nuovo-campus-per-rs-nel-regno-unito/ 2021-07-19T13:24:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tecnologie-avanzate-investimenti-sul-territorio-e-sostenibilita-a-colloquio-con-laura-gillio-meina-di-boston-scientific/ 2021-07-21T14:52:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-oncologia-il-paziente-dimenticato/ 2021-07-23T10:19:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-glaxosmithkline-e-vir-biotechnology-accordo-appalto-congiunto-con-ce-per-fornitura-sotrovimab/ 2021-07-28T12:54:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regional-summit-linnovazione-nella-vaccinazione-delladulto-in-liguria/ 2021-08-02T08:08:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/illumina-nel-mirino-dellantitrust-ue-per-lacquisizione-di-grail/ 2021-08-23T08:46:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-a-ottobre-di-dati-sul-vaccino-allema/ 2021-08-24T07:56:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-astrazeneca-funziona-la-terapia-anticorpale/ 2021-08-23T11:08:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-regeneron-roche-da-mhra-ok-a-cocktail-anticorpi/ 2021-08-23T12:41:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-investe-in-cina/ 2021-08-24T08:01:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-206-mld-di-dollari-di-investimenti-nei-prossimi-tre-anni/ 2021-08-24T15:33:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-pfizer-biontech-approvazione-piena-fda-cosa-cambiera/ 2021-08-24T11:56:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-kymriah-fallisce-endpoint-primario-in-studio-di-fase-avanzata/ 2021-08-24T13:05:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-aumenta-le-previsioni-dei-profitti/ 2021-08-25T08:19:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-ok-a-nuovi-impianti-europei-per-il-vaccino-pfizer-biontech/ 2021-08-25T08:43:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-vaccino-pfizer-biontech-fa-bene-alleurozona/ 2021-08-25T10:57:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/approvazione-vaccino-pfizer-biontech-le-reazioni-in-usa/ 2021-08-25T12:42:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-j-nuovi-dati-avvalorano-efficacia-dose-di-richiamo/ 2021-08-26T08:35:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-via-alla-procedura-negli-usa-per-dose-di-richiamo-vaccino-negli-over-16/ 2021-08-26T08:50:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-moderna-completato-processo-di-review-per-lok-definitivo-al-vaccino/ 2021-08-26T12:37:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-farmaco-contro-malattia-di-wilson-centra-obiettivo-dello-studio/ 2021-08-26T12:51:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-commissione-europea-approva-tafasitamab-in-combinazione-con-lenalidomide-per-il-trattamento-del-linfoma-diffuso-a-grandi-cellule-b-recidivato-o-refrattario/ 2021-08-30T07:57:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/autorizzato-bimekizumab-peril-trattamento-della-psoriasi-a-placche/ 2021-08-30T10:17:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-al-via-studio-testa-a-testa-vaccini-gsk-sk-astrazeneca/ 2021-08-31T08:19:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-tutti-vaccinati-i-partecipanti-allo-studio-di-novavax/ 2021-08-31T08:19:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-aumentano-le-prescrizioni-di-anticorpi-monoclonali-ai-pazienti-covid/ 2021-08-31T08:35:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-pronti-47-mld-per-25-mila-assunzioni-scaccabarozzi-opportunita-senza-precedenti/ 2021-08-31T14:06:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-pronta-ad-unacquisizione/ 2021-08-31T14:04:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/coronavirus-nuova-variante-identificata-in-sudafrica/ 2021-08-31T12:46:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-facebook-torna-il-feeling/ 2021-09-01T15:05:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/redhill-biopharma-funziona-il-farmaco-per-la-polmonite-da-covid/ 2021-09-01T09:41:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-ue-vaccinato-il-70-degli-adulti-ma-disparita-tra-stati-membri/ 2021-09-01T10:52:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-ce-a-rinvoq-per-over-12-con-dermatite-atopica-da-moderata-a-severa/ 2021-09-01T10:51:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-raccontare-la-scienza-con-un-cortometraggio/ 2021-09-01T12:19:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-vaccino-pfizerbiontech-sicuro-per-adolescenti-gravemente-malati/ 2021-09-01T12:55:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ministero-della-salute-giuseppe-ippolito-nuovo-dg-della-ricerca/ 2021-09-01T13:32:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-vaccino-sicuro-anche-per-adulti-con-allergie/ 2021-09-02T09:07:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ecdc-vaccini-covid-terza-dose-non-e-urgente/ 2021-09-02T14:56:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-fair-play-menarini-tra-leggende-dello-sport-di-ieri-e-di-oggi/ 2021-09-02T09:49:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-pfizer-e-msd-lanciano-nuovi-trial-su-antivirali-in-sperimentazione/ 2021-09-02T10:29:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/per-sobi-offerta-di-acquisto-da-8-mld-di-dollari/ 2021-09-02T14:15:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-collaborazione-population-health-con-nhs-per-inclisiran-nella-ascvd/ 2021-09-02T12:59:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-alla-fda-i-dati-per-la-terza-dose-del-vaccino-covid/ 2021-09-02T14:56:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-accetta-lofferta-di-acquisto-per-8-mld-di-dollari/ 2021-09-03T09:15:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-acquisisce-hill-rom/ 2021-09-03T09:40:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/studio-belga-con-vaccino-moderna-livello-anticorpi-piu-elevato-rispetto-a-pfizer-biontech/ 2021-09-03T10:10:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-sperimentata-con-successo-combo-sinovac-astrazeneca/ 2021-09-03T13:11:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-farmaci-e-vaccini-come-sara-il-procurement-nel-futuro/ 2021-09-03T15:11:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-dati-dalla-sorveglianza-real-world-confermano-sicurezza-per-vaccini-a-mrna/ 2021-09-08T12:34:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-sinovac-terza-dose-inverte-declino-attivita-anticorpi-contro-variante-delta/ 2021-09-08T12:02:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-campagna-terza-dose-iniziera-con-vaccino-pfizer/ 2021-09-08T12:33:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-sidemast-dagli-effetti-dei-cambiamenti-climatici-sulla-pelle-allaumento-del-melanoma-tra-i-giovani/ 2021-09-08T12:57:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-acquisisce-la-biopharma-usa-kadmon/ 2021-09-08T13:14:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-yovis-a-colloquio-con-chiara-francini/ 2021-09-08T13:25:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-la-gestione-value-based-del-paziente-con-ipovisione-cecita-a-colloquio-con-marina-cetola/ 2021-09-08T14:21:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-sindrome-di-guillain-barre-fra-i-possibili-effetti-collaterali-del-vaccino-astrazeneca/ 2021-09-09T08:58:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-covax-abbassa-lobiettivo-di-immunizzazione-dei-paesi-poveri/ 2021-09-09T13:50:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-consumer-healthcare-giuseppe-abbadessa-gm-della-neonata-business-unit-southern-europe/ 2021-09-09T09:32:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-torna-il-progetto-didattico-educativo-sulla-sma-con-le-avventure-della-smagliante-ada/ 2021-09-09T12:43:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-one-committment-in-depression-a-colloquio-con-fabio-de-luca-e-laura-lambertucci/ 2021-09-09T13:17:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/becton-dickinson-tipizzazione-immunologica-del-paziente-covid-a-colloquio-con-mara-bo/ 2021-09-09T13:25:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/automedicazione-perrigo-acquisisce-hra-pharma/ 2021-09-09T13:48:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terza-dose-vaccino-aifa-pronta-al-via-libera/ 2021-09-10T07:08:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-dlbcl-polatuzumab-vedotin-raggiunge-endpoint-primario-nello-studio-polarix/ 2021-09-10T09:28:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-ema-chiede-piu-dati-per-valutare-sputnik-e-sinovac/ 2021-09-10T10:00:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-punta-al-vaccino-pan-respiratorio/ 2021-09-10T10:20:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-alfathon-a-colloquio-con-biagio-oppi/ 2021-09-10T11:35:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-i-dati-dellottavo-rapporto-sulla-sorveglianza-dei-vaccini-covid19/ 2021-09-10T12:50:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-minds-ride-a-colloquio-con-michela-procaccini/ 2021-09-13T08:48:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-2-miliardi-di-dosi-di-vaccino-anti-covid-19-nel-2022/ 2021-09-13T09:13:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-al-congresso-esmo/ 2021-09-13T09:37:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-report-cdc-moderna-piu-efficace-nel-prevenire-i-ricoveri/ 2021-09-13T14:16:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/procurement-alfasigma-sceglie-la-soluzione-sap-ariba/ 2021-09-13T12:26:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-pazienti-inglesi-primi-in-europa-a-sperimentare-sotorasib-nsclc/ 2021-09-13T12:43:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-mastermind-a-colloquio-con-alessandro-lomonaco-e-virginia-montanari/ 2021-09-13T13:03:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gedeon-richter-modello-ibrido-kpis-a-colloquio-con-filomena-antinozzi/ 2021-09-13T14:15:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-oncologia-la-cultura-dellinnovazione/ 2021-09-14T09:15:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-punta-sul-business-dei-vaccini/ 2021-09-14T08:47:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-buone-risposte-anticorpali-dal-vaccino-contro-ebola/ 2021-09-14T09:43:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-aifa-a-entrectinib-terapia-innovativa-made-in-italy/ 2021-09-14T10:09:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-accordo-con-regenxbio-su-terapia-contro-malattie-croniche-della-retina/ 2021-09-14T10:25:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-italia-eroi-anonimi-a-colloquio-con-enrica-baraldi/ 2021-09-14T12:03:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/reckitt-benckiser-durex-safe-is-the-new-normal-a-colloquio-con-laura-savarese/ 2021-09-14T12:06:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/migliorare-la-salute-di-ogni-donna-il-nostro-obiettivo-intervista-allad-di-organon-italia-alper-alptekin/ 2021-09-14T13:19:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-a-pomezia-il-nuovo-centro-di-ricerca-e-sviluppo-marino-golinelli/ 2021-09-14T13:52:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-un-contest-per-ridurre-limpatto-della-dermatite-atopica-sulla-vita-familiare/ 2021-09-14T15:24:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/per-gestire-il-paziente-cronico-da-novartis-net-medica-italia-e-ibm-italia-arriva-openet/ 2021-09-14T15:45:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-oncology-e-ail-al-via-diamo-voce-al-futuro-la-campagna-di-sensibilizzazione-sui-tumori-ematologici/ 2021-09-14T16:24:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-un-hub-per-lafrica-con-lo-scopo-di-produrre-il-vaccino-di-moderna/ 2021-09-15T09:34:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-internalizza-i-media-digitali/ 2021-09-15T09:58:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/curevac-cancella-due-accordi-di-produzione-del-vaccino-sperimentale-contro-il-covid-19/ 2021-09-15T10:13:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-duodenoscopio-monouso-a-colloquio-con-piero-ferro/ 2021-09-15T10:35:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cochlear-telemedicina-per-pazienti-con-impianto-cocleare-a-colloquio-con-enrico-lanzoni/ 2021-09-15T10:39:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-accordo-emergent-providence-therapeutics-per-sviluppare-vaccino-mrna/ 2021-09-15T12:18:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/primo-rapporto-aifa-sulle-disuguaglianze-sociali-nelluso-dei-farmaci-chi-vive-nelle-aree-piu-disagiate-ne-consuma-di-piu/ 2021-09-15T13:49:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/laids-fa-meno-paura-ma-in-italia-si-contano-10-nuove-infezioni-al-giorno-le-riflessioni-a-camerae-sanitatis/ 2021-09-16T08:46:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abcellera-e-moderna-collaborano-per-sviluppare-terapie-basate-su-anticorpi/ 2021-09-16T09:07:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-necessaria-terza-dose-di-richiamo/ 2021-09-16T14:25:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-science-that-matters-a-colloquio-con-maurizio-binetti/ 2021-09-16T10:02:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/admenta-italia-lloydsfarmacia-farmacista-online-e-consulto-medico-h24-a-colloquio-con-vincenzo-masci/ 2021-09-16T10:06:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molteni-farmaceutici-in-finlandia-innovativo-trattamento-long-acting-per-la-dipendenza-da-oppioidi/ 2021-09-17T14:34:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-usa-biden-spinge-su-obbligo-vaccinale-per-lavoratori-aziende/ 2021-09-16T14:34:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/linfomi-linnovazione-ce-ora-bisogna-saperla-usare-bene-e-coinvolgere-di-piu-i-pazienti/ 2021-09-20T15:18:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-fda-approva-exkivity-contro-il-cancro-del-polmone/ 2021-09-17T09:28:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-governo-usa-acquista-dosi-aggiuntive-della-terapia-a-base-di-anticorpi-di-eli-lilly/ 2021-09-17T10:40:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-con-altems-un-corso-di-alta-formazione-sulla-comunicazione-istituzionale-per-le-associazioni-dei-pazienti/ 2021-09-17T12:19:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-lancia-hera-lunita-di-crisi-per-combattere-eventuali-pandemie-future/ 2021-09-17T12:45:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-chmp-che-raccomanda-lapprovazione-di-mepolizumab-per-altre-tre-patologie-causate-da-eosinofili/ 2021-09-17T14:12:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-conferma-la-valutazione-del-profilo-beneficio-rischio-su-zolgensma/ 2021-09-17T16:23:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-risultati-eclatanti-per-trastuzumab-deruxtecan-nel-tumore-al-seno/ 2021-09-20T09:35:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-risposta-tumorale-robusta-e-durevole-per-enhertu-nel-nsclc/ 2021-09-20T12:11:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esmo-2021-cancro-al-polmone-buoni-risultati-iniziali-da-datopotamab-deruxtecan/ 2021-09-20T12:30:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-con-ribociclib-letrozolo-sopravvivenza-piu-lunga-nel-carcinoma-della-mammella-avanzato/ 2021-09-20T13:31:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuova-terapia-mirata-con-radioligando-migliora-la-qualita-di-vita-nel-carcinoma-della-prostata-avanzato/ 2021-09-20T14:04:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grifols-pronta-ad-acquisire-la-rivale-tedesca-biotest/ 2021-09-20T14:56:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-cemiplimab-con-la-chemioterapia-migliora-la-sopravvivenza-nel-nsclc/ 2021-09-20T15:15:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-bioepis-biogen-fda-approva-biosimilare-di-lucentis-roche/ 2021-09-21T09:34:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-pfizer-e-biontec-vaccino-efficace-nella-fascia-di-eta-5-11-anni/ 2021-09-21T09:48:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-eli-lilly-fda-estende-autorizzazione-al-trattamento-con-cocktail-di-anticorpi/ 2021-09-21T13:13:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccine-confidence-educazione-sanitaria-nelle-scuole-per-aumentare-la-fiducia-nella-scienza-la-proposta-a-camerae-sanitatis/ 2021-09-21T12:58:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-j-j-con-seconda-dose-vaccino-efficacia-quasi-totale/ 2021-09-21T14:38:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-aifa-pubblica-elenco-dei-principali-farmaci-ad-attivita-immunosoppressiva/ 2021-09-22T15:02:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trials-clinici-studio-usa-in-alcuni-casi-gli-incentivi-finanziari-potrebbero-aumentare-la-partecipazione/ 2021-09-22T09:43:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-ce-accordo-di-appalto-congiunto-per-anticorpi-eli-lilly/ 2021-09-22T10:08:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-ue-chiede-a-usa-di-ammettere-anche-cittadini-vaccinati-con-astrazeneca/ 2021-09-22T12:38:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-bluebill-acquisisce-partecipazione-di-circa-10-milioni-di-euro/ 2021-09-23T15:17:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-investe-sulla-tecnologia-rna-auto-amplificante/ 2021-09-23T15:14:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bancel-ceo-moderna-la-pandemia-potrebbe-finire-tra-un-anno/ 2021-09-23T13:44:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk-lapproccio-one-health-in-sanita-una-sfida-per-il-management/ 2021-09-23T15:00:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-a-inizio-ottobre-decisione-su-terza-dose-pfizer-biontech/ 2021-09-24T09:25:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-19-novavax-chiede-ok-per-uso-in-emergenza-alloms/ 2021-09-24T09:43:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-oms-raccomanda-il-cocktail-di-anticorpi-di-regeneron-e-roche/ 2021-09-24T10:15:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-ok-chmp-a-paliperidone-palmitato-a-somministrazione-semestrale-nella-schizofrenia/ 2021-09-24T10:50:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/organon-lancia-prima-campagna-sulle-gravidanze-indesiderate/ 2021-09-27T09:36:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acceleron-in-vendita-per-11-mld-di-dollari/ 2021-09-27T14:49:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-cdc-usa-favorevoli-a-terza-dose-pfizerbiontech-per-gli-adulti-a-rischio-lavoratori-e-anziani/ 2021-09-27T10:19:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-produrra-un-farmaco-antitumorale/ 2021-09-27T12:57:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-marchio-ce-per-portafoglio-prodotti-accesso-radiale/ 2021-09-28T10:02:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/su-acceleron-lombra-lunga-di-msd/ 2021-09-28T10:17:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-via-a-trial-clinico-su-vaccino-a-mrna-contro-linfluenza/ 2021-09-28T13:40:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-moderna-ue-al-vaglio-di-eventuale-dose-di-richiamo/ 2021-09-28T10:55:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/camerae-sanitatis-cirrosi-epatica-appello-di-clinici-e-pazienti-per-migliorare-lassistenza/ 2021-09-28T16:06:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-acquisisce-caelum-biosciences/ 2021-09-29T09:24:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-fda-a-qulipta-per-la-prevenzione-dellemicrania/ 2021-09-29T10:02:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-al-via-la-campagna-tratti-di-respiro-per-sensibilizzare-sul-tumore-al-polmone/ 2021-09-29T12:57:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-accordo-di-licenza-con-shionogi-per-sviluppare-inibitore-dellintegrasi-dellhiv-di-terza-generazione/ 2021-09-29T13:30:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-gilead-remdesivir-efficace-nel-ridurre-i-ricoveri-ad-alto-rischio/ 2021-09-29T14:31:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/camerae-sanitatis-cronicita-dimenticate-loftalmologia-rivendica-il-suo-ruolo/ 2021-09-29T14:52:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-terminato-studio-usa-vaccino-covid-efficace-al-74/ 2021-09-30T09:38:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-msd-molnupiravir-efficace-anche-contro-le-varianti/ 2021-09-30T10:29:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-alleadv-i-dati-preliminari-dello-studio-be-bright-su-bimekizumab/ 2021-09-30T13:04:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-youtube-blocchera-contenuti-no-vax/ 2021-09-30T14:39:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terza-dose-pfizer-biontech-lunedi-ema-decide/ 2021-09-30T14:30:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-acquisisce-acceleron/ 2021-10-01T09:09:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-sempre-piu-feeling-con-i-social/ 2021-10-01T12:46:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgga-gsk-stop-a-partnership-su-farmaco-sperimentale-per-tumore-polmone/ 2021-10-01T14:06:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/guardare-con-fiducia-al-futuro-la-sanita-italiana-e-pronta-ad-affrontare-il-post-covid/ 2021-10-01T16:43:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-da-fda-breakthrough-therapy-designation-per-enhertu-nel-carcinoma-mammario-her2-positivo-non-resecabile/ 2021-10-04T13:23:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nobel-per-la-medicina-agli-scienziati-che-hanno-studiato-i-recettori-di-tatto-e-temperatura/ 2021-10-04T12:28:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/reuters-superati-i-5-milioni-di-decessi-per-covid/ 2021-10-04T13:22:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-italia-con-forest4life-persone-e-ambiente-al-centro-dellimpegno/ 2021-10-04T13:57:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-promettenti-risultati-per-amivantamab-negli-studi-chrysalis-nsclc/ 2021-10-04T15:49:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-lefficacia-del-vaccino-diminuisce-dopo-6-mesi/ 2021-10-05T09:36:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-ema-via-libera-a-terza-dose-pfizer-biontech/ 2021-10-05T16:12:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-al-via-campagna-di-sensibilizzazione-sulla-leucemia-linfatica-cronica/ 2021-10-05T10:30:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-bambino-gesu-vaccini-meno-efficaci-negli-immunocompromessi-occorre-la-terza-dose/ 2021-10-05T13:03:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-gottlieb-variante-delta-sara-lultima-ondata-pandemica-negli-usa/ 2021-10-06T09:07:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-msd-ema-valutiamo-rolling-review-per-molnupiravir/ 2021-10-06T09:23:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-eua-alla-fda-per-candidato-a-prevenire-il-covid/ 2021-10-06T09:55:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gli-scienziati-dei-vaccini-a-mrna-futuri-premi-nobel/ 2021-10-06T14:58:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-una-survey-sullimpatto-del-covid-tra-le-persone-che-soffrono-di-malattie-croniche-non-trasmissibili/ 2021-10-07T16:02:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dottore-ho-lasma-e-grave-al-via-la-campagna-di-comunicazione-sullasma-grave-con-le-storie-che-tolgono-il-fiato/ 2021-10-07T16:41:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-sanofi-buoni-risultati-da-somministrazione-contemporanea-antinfluenzale-e-anti-covid-a-mrna/ 2021-10-08T09:20:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-pfizer-e-biontech-chiesta-a-fda-eua-per-bambini-dai-5-agli-11-anni/ 2021-10-08T09:47:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-nuova-edizione-della-campagna-di-sensibilizzazione-c-come-curabile-per-sensibilizzare-sullepatite-c/ 2021-10-08T10:25:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-astrazeneca-cocktail-anticorpi-raggiunge-obiettivo-dello-studio/ 2021-10-11T08:52:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/22630/ 2021-10-11T09:10:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-moderna-nel-2022-1-mld-di-dosi-di-vaccino-in-piu-ai-paesi-a-basso-reddito/ 2021-10-11T15:30:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-cresce-lutile-operativo/ 2021-10-12T09:04:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-oms-raccomanda-dose-aggiuntiva-per-gli-immunocompromessi/ 2021-10-12T09:52:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-msd-punta-a-ok-fda-per-molnupiravir/ 2021-10-12T12:40:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-un-evento-per-parlare-di-sostenibilita-della-salute-del-futuro/ 2021-10-12T13:32:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-arriva-in-italia-isatuximab-mm/ 2021-10-12T14:20:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-regeneron-roche-dossier-ronapreve-allesame-dellema/ 2021-10-12T14:48:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-curevac-ritira-il-suo-candidato-vaccino/ 2021-10-12T15:14:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bundle-vap-nella-lotta-alle-ica-una-strategia-efficace-per-contrastare-la-polmonite-associata-a-ventilazione/ 2021-10-12T15:52:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-dubbi-fda-sulla-dose-booster/ 2021-10-13T08:58:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-con-scissione-unita-dei-farmaci-da-banco-nuove-sedi-per-le-due-societa/ 2021-10-13T09:11:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accesso-ai-farmaci-piu-veloce-a-camerae-sanitatis-gli-esperti-propongono-un-riordino-e-guardano-alla-francia/ 2021-10-14T13:34:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cambio-al-vertice-di-alfasigma-il-nuovo-ceo-sara-francesco-balestrieri/ 2021-10-13T12:43:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-aifa-ok-rimborsabilita-ranibizumab-nella-rop/ 2021-10-13T13:18:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-il-vaccino-russo-sputnik-light-e-efficace-al-70-contro-la-variante-delta/ 2021-10-14T09:07:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-nei-prossimi-anni-investira-nei-siti-di-produzione/ 2021-10-14T09:24:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-ue-possibile-accordo-con-msd-su-fornitura-molnupiravir/ 2021-10-14T14:30:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-italia-gilles-renacco-nuovo-presidente/ 2021-10-14T14:36:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-doctolib-italia/ 2021-10-14T14:34:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-mondo-del-pharma-torna-in-fiera-con-cphl-worlwide-a-milano/ 2021-10-14T14:29:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-moderna-panel-fda-raccomanda-la-dose-booster-del-vaccino/ 2021-10-15T08:44:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-ema-avvia-rolling-review-terapia-di-astrazeneca/ 2021-10-15T12:43:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-il-30-novembre-si-discute-su-molnupiravir-di-msd/ 2021-10-15T13:03:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk-come-ripartire-dopo-gli-insegnamenti-del-covid/ 2021-10-15T15:51:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-sfide-dei-farmacisti-ospedalieri-per-traghettare-il-ssn-nel-futuro-le-interviste-di-daily-health-industry/ 2021-10-17T14:51:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-valneva-positivi-i-dati-di-fase-3-del-candidato-vaccino/ 2021-10-18T15:33:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-candidato-sla-non-centra-obiettivo-principale-dello-studio-ma-dati-comunque-positivi/ 2021-10-18T09:53:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-alessandro-crevani-nuovo-gm-della-business-unit-general-medicines/ 2021-10-18T13:21:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-allema-i-dati-per-lok-a-uso-in-emergenza-del-vaccino-nella-fascia-5-11-anni/ 2021-10-18T13:41:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-a-monza-e-anagni-la-produzione-del-vaccino-pfizer-e-biontech/ 2021-10-18T15:17:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-valneva-protezione-simile-ad-astrazeneca-ma-meno-effetti-collaterali/ 2021-10-19T08:41:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-acoi-johnson-johnson-medical-italia-a-supporto-dei-chirurghi-italiani/ 2021-10-19T09:56:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-fda-dose-di-richiamo-anche-con-vaccino-diverso/ 2021-10-19T12:22:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-vaccino-moderna-per-gli-adolescenti-cautela-fda/ 2021-10-19T14:52:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/22748/ 2021-10-19T15:36:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-migliora-le-previsioni-per-il-2021/ 2021-10-20T08:33:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bandi-gilead-con-la-decima-edizione-oltre-1-milione-di-euro-per-ricerca-e-associazioni-pazienti/ 2021-10-20T09:12:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-un-futuro-sempre-piu-sostenibile/ 2021-10-20T15:41:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/studio-cdc-vaccino-pfizer-biontech-efficace-al-93-nel-prevenire-i-ricoveri-nella-fascia-12-18-anni/ 2021-10-20T12:47:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-e-radius-elacestrant-centra-endpoint-primari-dello-studio-emerald/ 2021-10-20T14:48:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-come-cambia-la-terapia-del-tumore-al-seno-her2/ 2021-10-21T08:51:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-chmp-a-risankizumab-nellartrite-psoriasica/ 2021-10-21T09:36:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-la-start-up-italiana-welmed-raccoglie-5-milioni-di-euro/ 2021-10-21T12:14:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ok-a-dosi-booster-di-moderna-e-j/ 2021-10-21T12:38:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-italia-limportanza-di-informare-nel-mese-della-prevenzione-del-cancro-del-seno/ 2021-10-22T09:13:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-da-comitato-cdc-ok-a-shingrix-in-over-19-immunocompromessi/ 2021-10-22T10:13:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-19-terza-dose-pfizer-biontech-efficace-al/ 2021-10-22T12:53:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-19-al-via-studi-dei-candidati-di-shionogi-e-daiichi-sankyo/ 2021-10-22T13:10:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-icona-unindagine-per-conoscere-i-desiderata-e-limpatto-della-terapia-antiretrovirale-nelle-persone-con-hiv/ 2021-10-22T15:43:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-interessata-ad-aurinia-pharmaceuticals/ 2021-10-25T09:05:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-pfizer-biontech-nella-fascia-5-11-anni-lefficacia-e-del-90/ 2021-10-25T09:27:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-oggi-il-verdetto-ema-sulla-dose-di-richiamo/ 2021-10-25T15:31:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-vende-sandoz/ 2021-10-26T09:53:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-ok-ema-a-dose-di-richiamo-moderna-negli-adulti/ 2021-10-26T13:12:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/richiamo-vaccino-j-settimana-decisiva/ 2021-10-26T13:59:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antimicrobico-resistenza-attesa-per-il-2021-la-bozza-di-piano-finanziamenti-per-40-mln-di-euro-allanno-lannuncio-a-camerae-sanitatis/ 2021-10-26T14:05:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daichii-sankyo-italia-progetto-value-based-healthcare-ecosystem-per-un-nuovo-ecosistema-di-gestione-delle-patologie-cardiovascolari/ 2021-10-27T09:15:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-pfizer-biontech-da-panel-fda-raccomandazione-per-la-fascia-5-11-anni/ 2021-10-27T14:41:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-application-alla-fda-per-approvazione-farmaco-sperimentale-per-lalzheimer/ 2021-10-27T10:21:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-al-fianco-di-apiafco-per-i-pazienti-psoriasici/ 2021-10-27T13:00:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-accordo-con-senegal-e-ruanda-per-costruire-stabilimenti-di-produzione-vaccini-a-mrna/ 2021-10-27T13:11:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bancel-ceo-moderna-presto-richiesta-a-fda-per-vaccino-ai-bambini-6-11-anni/ 2021-10-28T09:09:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-alza-le-stime-sui-profitti-dopo-un-ottimo-q3/ 2021-10-28T15:55:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-q3-sotto-le-stime-ripresa-nel-prossimo-trimestre/ 2021-10-28T14:14:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-alza-le-stime-annuali-di-profitto/ 2021-10-28T15:54:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-il-nuovo-vaccino-anti-covid-costera-meno-di-10-euro/ 2021-10-29T09:05:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-q3-trascinato-da-remdesivir/ 2021-10-29T09:36:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-50-milioni-di-dosi-agli-usa-per-vaccinare-i-bambini/ 2021-10-29T12:37:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prix-galien-italia-2021-tre-riconoscimenti-per-novartis/ 2021-10-29T13:09:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-pfizer-biontech-ok-fda-per-5-11-anni/ 2021-11-01T13:28:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-cede-a-covis-pharma-i-diritti-su-due-farmaci-per-la-bpco/ 2021-11-02T17:00:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-nessun-interesse-per-aurinia-pharmaceuticals/ 2021-11-02T10:13:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-e-covid-al-via-la-prima-edizione-del-cipomo-day-2021/ 2021-11-02T11:13:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-covid-moderna-slitta-decisione-fda-per-fascia-di-eta-12-17-anni/ 2021-11-02T13:55:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-bene-il-q3-ma-previsioni-in-calo-per-la-fine-dellanno/ 2021-11-03T09:51:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-conferma-la-stima-sullutile-netto-per-lintero-anno/ 2021-11-03T10:05:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-stop-ema-a-rolling-review-per-i-monoclonali-eli-lilly/ 2021-11-03T10:23:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sostenibilita-ambientale-boehringer-ingelheim-aggiorna-i-propri-impegni/ 2021-11-03T11:33:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zentiva-italia-lancia-il-suo-primo-biosimilare/ 2021-11-03T11:56:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-anche-cdc-raccomandano-vaccino-pfizer-biontech-nella-fascia-5-11-anni/ 2021-11-03T13:56:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-e-online-lapp-care-dedicata-a-chi-soffre-di-malattie-infiammatorie-immunomediate/ 2021-11-03T15:52:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-ok-a-dose-booster-per-vaccinati-j/ 2021-11-03T18:19:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-compra-le-quote-novartis-per-20-mld-di-dollari/ 2021-11-04T09:40:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-aumenta-previsioni-di-profitto-per-il-2021/ 2021-11-04T09:56:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-obiettivo-leadership-del-mercato-dellobesita/ 2021-11-04T15:10:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-da-vendite-vaccino-covid-65-mld-di-dollari-entro-il-2022/ 2021-11-04T16:22:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-19-astrazeneca-ema-valuta-dose-booster/ 2021-11-05T10:43:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-taglia-previsioni-vendite-del-vaccino-covid-19/ 2021-11-05T10:35:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-fatturato-del-q3-oltre-le-stime-degli-analisti/ 2021-11-05T10:59:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-nellera-covid-realta-regionali-a-confronto-nel-primo-cipomo-day/ 2021-11-05T15:53:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sviluppo-sostenibile-limpegno-di-boehringer-ingelheim-con-il-pilastro-more-potential/ 2021-11-07T11:15:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-nuovo-antivirale-di-pfizer-riduce-dell89-rischio-forme-gravi/ 2021-11-08T10:29:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/report-le-ricerche-online-in-ambito-sanitario-sono-transgenerazionali/ 2021-11-08T11:41:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mariangela-amoroso-alla-guida-del-team-medico-di-sanofi-italia/ 2021-11-08T14:05:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-buoni-risultati-per-daprodustat-anemia/ 2021-11-08T14:59:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/atos-medical-va-a-coloplast-per-25-miliardi-di-dollari/ 2021-11-09T10:47:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-gli-anticorpi-di-regeneron-proteggono-fino-a-8-mesi-dopo-una-singola-dose/ 2021-11-09T16:01:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antivirali-covid-ue-in-trattative-con-msd-e-pfizer/ 2021-11-09T14:47:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/netcomm-il-programma-per-la-sanita-digitale-nel-pnrr/ 2021-11-09T16:54:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epilessia-a-camerae-sanitatis-lappello-di-clinici-e-pazienti-sia-inserita-nella-lista-delle-malattie-tempo-dipendenti/ 2021-11-10T11:08:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-al-cphi-2021-tra-i-leader-del-contract-manufacturing-farmaceutico/ 2021-11-10T13:59:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bando-fondazione-roche-per-la-ricerca-indipendente-premiati-i-vincitori-della-5-edizione/ 2021-11-10T14:32:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-way-together-al-via-la-terza-edizione-focus-hiv/ 2021-11-10T15:38:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-letterario-angelo-zanibelli-ecco-i-vincitori/ 2021-11-11T10:16:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-ce-anche-il-candidato-di-roche/ 2021-11-11T10:54:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-valneva-firma-accordo-con-lue/ 2021-11-11T11:25:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-moderna-entro-due-mesi-decisione-ema-per-6-11-anni/ 2021-11-11T14:09:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-vaccine-confidence-come-contrastare-la-diffidenza-vaccinale/ 2021-11-11T15:04:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-ema-via-libera-agli-anticorpi-monoclonali-ronapreve-e-regkirona/ 2021-11-12T18:05:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibsa-raccoglie-la-sfida-della-sostenibilita/ 2021-11-12T10:21:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-aduhelm-alzheimer-riduce-anche-livelli-di-proteina-tau/ 2021-11-12T13:57:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-gsk-vir-biotechnology-somministrazione-intramuscolare-di-sotrovimab-non-inferiore-a-quella-endovenosa/ 2021-11-12T15:21:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-prospettive-di-fine-anno-in-rialzo/ 2021-11-15T10:37:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/robert-califf-alla-guida-della-fda/ 2021-11-15T11:02:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-torna-la-campagna-oltre-la-pelle-la-prevenzione-al-centro/ 2021-11-15T14:29:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rivoluzione-johnson/ 2021-11-15T15:17:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-50-milioni-di-euro-a-favore-delle-imprese-a-vocazione-sociale/ 2021-11-15T16:35:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/3m-littman-arriva-in-italia-lo-stetoscopio-digitale-core/ 2021-11-16T10:11:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-fornitura-vaccino-covid-raggiunge-i-due-mld-di-dosi-in-tutto-il-mondo/ 2021-11-16T15:36:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antivirali-covid-dopo-laccordo-con-msd-lindiana-dr-reddy-pronta-a-lavorare-anche-con-pfizer/ 2021-11-16T10:51:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-scientifica-in-italia-abbiamo-le-menti-ma-non-un-sistema-che-le-valorizzi-le-riflessioni-acamerae-sanitatis/ 2021-11-16T15:38:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/innovazione-e-valore-le-sfide-future-dellindustria-farmaceutica/ 2021-11-17T10:42:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-pfizer-eua-a-fda-per-antivirale-paxlovid/ 2021-11-17T11:20:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-ok-ce-a-diroximel-fumarato-nella-sm-recidivante-remittente/ 2021-11-17T14:52:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-panel-ema-vota-contro-approvazione-aduhelm-alzheimer/ 2021-11-18T11:38:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-terapia-covid-protegge-all83-per-sei-mesi/ 2021-11-18T16:23:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-su-vaccino-covid-decisione-ema-nelle-prossime-settimane/ 2021-11-18T14:27:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-investe-in-una-start-up-ai/ 2021-11-18T14:51:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-curevac-nei-prossimi-mesi-studi-clinici-su-vaccino-di-seconda-generazione/ 2021-11-19T10:13:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cavaleri-ema-a-inizio-2022-valutazione-terapia-astrazeneca-per-covid/ 2021-11-19T10:30:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-ce-a-skyrizi-nellartrite-psoriasica/ 2021-11-19T12:10:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-acquisisce-dicerna-per-oltre-3-mld-di-dollari/ 2021-11-19T13:47:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/j-14-nuovi-farmaci-entro-il-2025/ 2021-11-19T14:07:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-usa-prenotano-10-milioni-di-cicli-di-paxlovid/ 2021-11-19T14:41:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-con-reimagine-un-progetto-formativo-per-i-giovani/ 2021-11-22T10:58:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-ce-a-gavreto-nel-nsclc-avanzato-positivo-per-la-fusione-di-ret/ 2021-11-22T11:28:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-da-fda-revisione-accelerata-per-candidato-contro-il-melanoma/ 2021-11-22T13:57:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/governance-farmaceutica-va-rivisto-il-modello-organizzativo/ 2021-11-22T14:44:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-parere-positivo-ema-su-antivirale-msd/ 2021-11-22T15:04:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-premia-tre-proposte-di-ricerca-per-il-controllo-della-prrs/ 2021-11-22T15:36:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-pfizer-vaccino-protegge-a-lungo-termine-gli-adolescenti/ 2021-11-23T10:24:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-accordo-con-arrowhead-pharmaceuticals-per-sviluppo-candidato-nash/ 2021-11-23T10:46:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-accordo-con-cinese-baidu-per-algoritmo-di-sequenziamento-mrna/ 2021-11-23T13:37:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-nasce-la-bu-malattie-rare-ad-alessandro-lattuada-la-direzione/ 2021-11-23T14:11:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-progetto-per-la-salute-mentale-post-pandemia-in-italia/ 2021-11-23T14:29:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-roche-e-fadoi-libro-bianco-la-ricerca-biomedica-e-il-rapporto-pubblico-privato/ 2021-11-23T14:46:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-lue-apre-il-dibattito-sulla-necessita-della-dose-booster-per-viaggiare/ 2021-11-24T14:51:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-accordo-per-licenza-globale-test-sierologico-covid-19/ 2021-11-24T13:47:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-soriot-ceo-astrazeneca-difende-il-suo-vaccino/ 2021-11-24T14:52:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-ok-fda-a-farmaco-contro-infezione-post-trapianto/ 2021-11-25T10:41:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ecdc-dose-booster-vaccino-covid-per-tutti-gli-over-40/ 2021-11-25T11:00:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-oms-andra-in-russia-per-valutare-sputnik-v/ 2021-11-25T11:41:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-ema-autorizza-vaccino-pfizer-per-la-fascia-511-anni/ 2021-11-25T14:31:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-in-italia-con-elio-e-le-storie-tese-per-laderenza-terapeutica/ 2021-11-26T13:07:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-allarme-variante-sudafricana/ 2021-11-28T15:54:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-per-viaggiare-limite-di-nove-mesi-a-validita-vaccino/ 2021-11-26T11:36:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-richiamo-del-vaccino-contro-il-covid-19-obbligatorio-per-chi-vuole-viaggiare-nel-blocco-dei-27/ 2021-11-26T14:49:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-alle-nazioni-omicron-rischio-diffusione-globale-altissimo/ 2021-11-29T10:22:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-novavax-e-inovio-al-lavoro-sulla-nuova-variante/ 2021-11-29T10:44:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-variante-omicron-astrazeneca-valuta-efficacia-vaccino-e-antivirale/ 2021-11-29T14:51:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-msd-da-dati-aggiornati-molnupiravir-meno-efficace-del-previsto/ 2021-11-29T14:50:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-tumore-al-polmone-arriva-in-italia-lorlatinib/ 2021-11-29T16:26:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-al-riacquisto-delle-azioni-novartis/ 2021-11-29T15:30:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/variante-omicron-limpegno-del-g7-salute/ 2021-11-29T16:07:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/come-declinare-il-pnrr-nella-pratica/ 2021-11-30T10:12:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bancel-ceo-moderna-rischio-scarsa-efficacia-vaccini-contro-variante-omicron/ 2021-11-30T15:16:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-celltrion-la-terapia-anticorpale-arriva-in-europa/ 2021-11-30T10:45:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-pfizer-80-milioni-di-cicli-di-paxlovid-entro-il-2022/ 2021-11-30T14:15:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-biontech-al-lavoro-su-vaccino-contro-variante-omicron/ 2021-11-30T15:17:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dermatologia-galderma-acquisisce-lamericana-alastin/ 2021-11-30T15:08:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-i-quattro-90-della-sfida-allhiv-alla-luce-della-revisione-della-legge-135-90/ 2021-11-30T15:44:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-per-clinici-e-pazienti-serve-meno-ospedale-e-piu-territorio-le-riflessioni-a-camerae-sanitatis/ 2021-11-30T15:52:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-stiamo-investendo-per-arrivare-a-terapie-con-somministrazione-semestrale-intervista-a-valentino-confalone-gilead-sciences-italia/ 2021-11-30T16:40:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-hiv-sondaggio-viiv-healthcare-40-anni-dopo-persistono-stigma-e-pregiudizi/ 2021-12-01T10:24:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-cambi-al-vertice-andrea-recordati-presidente-del-consiglio-di-amministrazione-e-robert-koremans-ad/ 2021-12-01T10:53:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/belantamab-mafodotin-nuova-frontiera-nella-lotta-al-mieloma-multiplo/ 2021-12-01T10:58:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-fda-valuta-efficacia-contro-la-variante-omicron/ 2021-12-01T11:09:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-dormitzer-ex-pfizer-nominato-capo-della-rd-vaccini-globale/ 2021-12-01T17:17:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-panel-fda-dice-si-a-molnupiravir/ 2021-12-01T13:49:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-acquisisce-origimm-biotechnology-ed-espande-la-pipeline-dei-vaccini-mrna/ 2021-12-01T14:36:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-a-marzo-2022-pronta-la-dose-booster-contro-variante-omicron/ 2021-12-02T10:31:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-crescita-annua-del-4-fino-al-2026/ 2021-12-02T10:48:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-test-diagnostici-diasorin-rilevano-anche-variante-omicron/ 2021-12-02T10:59:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sotrovimab-attivo-contro-le-mutazioni-chiave-della-variante-omicron/ 2021-12-02T14:42:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-in-ue-vaccino-per-5-11-anni-a-partire-dal-13-dicembre/ 2021-12-02T14:33:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-ema-avvia-rolling-review-sul-vaccino-valneva/ 2021-12-02T15:05:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-torna-afiancodelcoraggio-il-premio-che-da-voce-ai-racconti-al-maschile-dedicati-alle-donne-con-tumore/ 2021-12-03T11:33:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-sviluppa-nuovi-test-kit-di-ricerca-della-variante-omicron/ 2021-12-03T14:13:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-i-vaccini-guideranno-la-crescita-verso-il-2030/ 2021-12-03T14:40:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/23251/ 2021-12-03T15:58:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-novavax-allo-studio-di-un-vaccino-specifico-contro-omicron/ 2021-12-03T15:16:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-vaccini-mrna-piu-protettivi-se-terza-dose-e-offerta-12-settimane-dopo-la-seconda/ 2021-12-03T16:04:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/variante-omicron-sahin-ceo-biontech-vaccino-ad-hoc-probabilmente-necessario/ 2021-12-06T10:30:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-shopping-nei-tumori-rari-acquisita-eusa-pharma/ 2021-12-06T11:30:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-eli-lilly-da-fda-ok-ad-anticorpi-monoclonali-per-gli-under-12/ 2021-12-06T14:07:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-ce-anche-la-spagnola-hipra/ 2021-12-06T14:30:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scienziata-vaccino-oxford-astrazeneca-la-prossima-pandemia-potrebbe-essere-piu-letale/ 2021-12-06T16:44:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/variante-omicron-gskvir-biotechnology-sotrovimab-efficace-contro-tutte-le-mutazioni-della-proteina-spike/ 2021-12-07T10:05:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-antimicrobico-resistenza-prevenzione-del-rischio-e-valore-della-pratica-vaccinale/ 2021-12-07T10:13:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ema-estende-uso-roactemra-nel-trattamento-del-covid19/ 2021-12-07T16:11:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-studio-oxford-la-vaccinazione-eterologa-e-efficace-e-sicura/ 2021-12-07T13:44:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/niraparib-disponibile-come-terapia-di-mantenimento-in-prima-linea/ 2021-12-07T11:24:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-anche-i-pazienti-oncologici-traggono-benefici-dai-vaccini-a-mrna/ 2021-12-07T11:27:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-da-studio-emerald-dati-positivi-per-elacestrant-tumore-al-seno/ 2021-12-09T10:26:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-le-avventure-della-smagliante-ada-vincono-il-premio-omar/ 2021-12-09T11:40:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-aumento-delle-risposte-anticorpali-con-richiamo-vaccino-johnson-johnson-sei-mesi-dopo-due-dosi-di-pfizer/ 2021-12-09T12:05:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-nel-2022-stabilimenti-europei-produrranno-oltre-3-mld-di-dosi-di-vaccinin/ 2021-12-09T13:54:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-ok-fda-a-cocktail-anticorpi-astrazeneca/ 2021-12-09T16:00:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/varianti-covid-gli-esperti-servono-vaccini-meno-specifici/ 2021-12-09T15:23:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-una-podcast-story-per-raccontare-il-cancro-senza-stereotipi/ 2021-12-10T10:05:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-cavaleri-ema-dose-booster-anche-dopo-3-mesi-dal-ciclo-vaccinale/ 2021-12-10T10:29:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-ecco-i-nomi-della-nuova-leadership/ 2021-12-10T13:47:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ok-dose-booster-a-1617emmi/ 2021-12-12T16:43:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-combo-ivosidenib-azacitidina-migliora-sopravvivenza-nella-lma-con-mutazione-di-idh1/ 2021-12-13T10:28:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-pfizer-biontech-studio-israeliano-con-la-dose-booster-protezione-elevata-da-variante-omicron/ 2021-12-13T11:05:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-nuove-importanti-conferme-per-trastuzumab-deruxtecan-nel-tumore-al-seno/ 2021-12-13T14:04:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-europa-divisa-sui-vaccini-ai-bambini/ 2021-12-13T14:39:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cart-dialogo-aperto-tra-gli-stakeholder-nazionali-per-valorizzare-le-esperienze/ 2021-12-13T15:06:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-narashimhan-conferma-linteresse-allacquisto-dellunita-dei-generici-di-novartis/ 2021-12-13T15:40:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-valutazione-accelerata-ema-per-olipudasi-alfa-nellasmd/ 2021-12-14T10:16:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/u-s-army-studia-vaccino-contro-covid-19-e-altri-virus-respiratori/ 2021-12-14T10:49:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-su-youtube-la-nuova-playlist-dedicata-alle-distrofie-retiniche-ereditarie/ 2021-12-14T11:34:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/guerbet-e-bracco-imaging-accordo-di-collaborazione-strategica-globale-per-gadopiclenolo/ 2021-12-14T13:27:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-67-miliardi-di-dollari-per-acquisire-arena-pharmaceuticals/ 2021-12-14T13:43:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-investira-258-miliardi-di-dollari-per-siti-di-produzione-in-danimarca/ 2021-12-14T13:54:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-gruppo-chiesi-presenta-al-mise-il-nuovo-hub-per-lo-sviluppo-di-prodotti-biologici/ 2021-12-14T15:33:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-del-sangue-con-innovazione-vantaggi-per-pazienti-e-sostenibilita-del-sistema-presto-curabile-7580-dei-pazienti/ 2021-12-15T10:27:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-pfizer-antivirale-orale-efficace-quasi-al-90/ 2021-12-15T10:43:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-gsk-efficace-dose-booster-candidato-vaccino-anti-covid19/ 2021-12-15T11:03:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epilessia-prossimita-innovazione-e-ascolto-le-parole-chiave-per-curare-il-paziente-e-non-solo-la-malattia/ 2021-12-15T14:59:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-920-mln-di-dollari-per-unimmunoterapia-sperimentale/ 2021-12-15T14:32:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-parte-oggi-la-iv-edizione-il-20-gennaio-la-celebrazione-dei-best-of-2021/ 2021-12-15T15:00:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-e-fofi-al-via-il-premio-farmacistagreen/ 2021-12-15T16:09:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-cronicita-dimenticate-recupero-dei-pazienti-fragili/ 2021-12-16T07:55:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/simg-simit-e-sifo-una-sinergia-per-luso-degli-anticorpi-monoclonali-nel-covid/ 2021-12-16T10:17:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-dal-congresso-ash-nuove-evidenze-per-belantamab-mafodotin-mm/ 2021-12-16T11:16:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-vaccino-per-adulti-contro-il-virus-respiratorio-sinciziale-mantiene-unefficacia-significativa/ 2021-12-16T13:43:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-nuovi-dati-importanti-su-datopotamab-deruxtecan-tumore-al-seno/ 2021-12-16T14:18:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/paolo-foggi-nominato-chair-dello-scientific-advice-working-party-dellema/ 2021-12-16T14:45:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-con-dose-booster-tassi-infezione-da-variante-omicron-dieci-volte-inferiori/ 2021-12-16T14:55:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-utili-sopra-le-stime-per-il-2022/ 2021-12-16T15:19:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-accesso-precoce-ai-farmaci-in-italia-limiti-opportunita-e-prospettive/ 2021-12-17T08:49:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-sobi-parere-positivo-chmp-per-kineret-nel-trattamento-di-pazienti-adulti-con-polmonite/ 2021-12-17T11:31:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diasorin-cala-la-domanda-dei-test-per-il-covid/ 2021-12-17T11:39:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-bene-le-sentenze-del-tar-lazio-sul-payback-2019/ 2021-12-17T13:29:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-covid-novavax-prima-di-natale-probabile-ok-ema/ 2021-12-17T13:55:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-e-vir-biotechnology-ok-ce-a-sotrovimab-nel-trattamento-precoce-del-covid-19/ 2021-12-17T14:20:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molecular-tumour-board-la-nuova-sfida-nelloncologia-di-precisione/ 2021-12-20T10:34:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-amgen-ok-fda-a-tezspire-asma/ 2021-12-20T11:21:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-in-italia-la-foto-dellimpatto-in-uno-studio/ 2021-12-20T14:09:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-j-sinopharm-e-sputnik-potrebbero-non-essere-efficaci-contro-la-variante-omicron/ 2021-12-20T14:52:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-ema-autorizza-vaccino-novavax/ 2021-12-20T15:14:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/studio-imperial-college-da-variante-omicron-rischio-reinfezione-cinque-volte-piu-alto-rispetto-a-delta/ 2021-12-20T15:48:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-accordo-con-beigene-per-terapia-antitumorale-un-affare-da-1-miliardo-di-dollari/ 2021-12-21T09:45:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-shopping-nel-biotech-usa-acquisita-amunix-pharmaceuticals/ 2021-12-21T10:05:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bancel-ceo-moderna-pronti-a-produrre-dose-contro-variante-omicron/ 2021-12-21T14:02:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-andrea-pecci-nuovo-customer-excellence-innovation-director/ 2021-12-21T14:17:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-novavax-disponibile-in-europa-allinizio-del-2022/ 2021-12-21T16:16:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-menarini-e-karyopharm-therapeutics-accordo-per-la-commercializzazione-di-nexpovio-selinexor/ 2021-12-21T15:05:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-epilessia-le-sfide-di-oggi/ 2021-12-22T08:32:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-oxford-mirano-alla-produzione-di-un-vaccino-specifico-contro-omicron/ 2021-12-22T15:05:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/microsoft-via-libera-dellantitrust-europeo-allacquisizione-di-nuance-ai-per-16-mld-di-dollari/ 2021-12-22T10:34:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-con-la-lampada-di-aladino-per-la-magia-del-natale/ 2021-12-22T11:06:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-sfida-del-futuro-somministrare-i-farmaci-a-casa-del-paziente/ 2021-12-22T13:45:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-dose-booster-aiuta-contro-omicron-ma-necessari-piu-dati-sulla-variante/ 2021-12-22T14:01:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-approva-vaccino-novavax/ 2021-12-23T08:26:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/papa-francesco-accoglie-in-udienza-il-premio-fair-play-menarini/ 2021-12-23T10:16:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-pfizer-ok-stati-uniti-a-uso-domiciliare-paxlovid/ 2021-12-23T10:51:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-variante-omicron-booster-astrazeneca-efficace/ 2021-12-23T15:34:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-acquisisce-gyroscope-per-15-mld-di-dollari/ 2021-12-23T14:09:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-inizia-la-sperimentazione-di-enhertu-nel-nsclc-come-terapia-di-prima-linea/ 2021-12-23T16:25:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-vaccino-anti-covid-protegge-per-sei-mesi/ 2022-01-10T09:53:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-partnership-con-mammoth-biosciences-per-sviluppare-terapia-genica/ 2022-01-10T10:05:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-nuovo-prodotto-sinopharm-a-base-di-proteine-efficace-come-booster-contro-omicron/ 2022-01-10T14:59:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-investe-nellai-accordo-con-exscientia-per-sviluppare-fino-a-15-nuovi-farmaci/ 2022-01-10T15:03:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stryker-acquisisce-vocera-communications-piattaforma-di-assistenza-digitale/ 2022-01-10T11:06:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizerbiontech-2-dosi-vaccino-proteggono-i-bambini-da-una-rara-complicazione-del-covid/ 2022-01-10T14:58:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bourla-ceo-pfizer-a-marzo-possibile-lancio-vaccino-contro-omicron/ 2022-01-11T09:54:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-italia-nuovo-modello-organizzativo-che-scommette-sul-territorio/ 2022-01-11T10:22:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-nel-2022-oltre-18-mld-di-dollari-dalle-vendite-del-vaccino-covid/ 2022-01-11T10:35:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-richiesta-approvazione-farmaco-novartismolecular-partners-potrebbe-arrivare-entro-fine-mese/ 2022-01-11T17:30:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-crescita-delle-vendite-a-una-cifra-nel-2022/ 2022-01-11T13:37:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-anticorpo-sperimentale-di-eli-lilly-neutralizza-omicron-in-vitro/ 2022-01-11T15:57:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jazz-pharmaceuticals-patrizia-olivari-general-manager-in-italia/ 2022-01-11T17:01:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-vaccino-pfizer-altamente-efficace-nel-prevenire-lospedalizzazione-degli-adolescenti/ 2022-01-13T16:34:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-dose-booster-vaccino-induce-risposta-anticorpale-contro-omicron/ 2022-01-13T10:41:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-rafal-kaminski-e-il-nuovo-direttore-scientifico/ 2022-01-13T11:04:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-ok-ce-a-lumykras-nel-nsclc-in-stadio-avanzato-con-mutazione-kras/ 2022-01-13T11:53:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ghebreyesus-oms-omicron-pericolosa-soprattutto-per-i-non-vaccinati/ 2022-01-13T14:13:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-focus-su-immunologia-e-immuno-oncologia/ 2022-01-13T16:09:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grunenthal-italia-a-monica-caserta-il-market-access-government-affairs/ 2022-01-13T15:22:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-loms-raccomanda-i-farmaci-di-eli-lilly-e-gsk-vir/ 2022-01-16T16:08:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-verso-nuove-potenziali-acquisizioni/ 2022-01-16T17:01:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/per-il-2022-eli-lilly-punta-su-diabete-e-malattia-di-alzheimer/ 2022-01-14T13:26:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-il-2022-sara-lanno-di-novavax/ 2022-01-14T15:50:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-diagnostics-un-kit-per-rilevare-la-variante-omicron/ 2022-01-17T09:44:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-aifa-a-riborsabilita-budesonide-glicopirronio-formoterolo-fumarato/ 2022-01-17T10:31:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-arriva-in-italia-dovprela-per-la-tb-a-estesa-farmacoresistenza/ 2022-01-17T11:02:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ok-a-farmaci-di-abbvie-e-pfizer-contro-la-dermatite-atopica/ 2022-01-17T11:44:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/europa-si-riaffaccia-il-rischio-twindemia/ 2022-01-17T14:35:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/studio-sudafricano-booster-johnson-efficace-all85-contro-ricoveri-per-variante-omicron/ 2022-01-17T15:07:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-pfizer-investe-in-francia-per-la-produzione-di-paxlovid/ 2022-01-18T10:47:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shionogi-al-via-trial-clinico-di-fase-iii-su-vaccino-anti-covid/ 2022-04-06T13:28:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bancel-ceo-moderna-a-marzo-il-vaccino-contro-omicron/ 2022-01-18T13:59:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-nella-corsa-contro-omicron-anche-lindiana-gennova-biopharmaceuticals/ 2022-01-18T14:12:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-e-mabgenesis-accordo-per-sviluppo-anticorpi-monoclonali-per-i-cani/ 2022-01-18T15:24:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-alla-pharma-non-concentratevi-solo-su-omicron/ 2022-01-19T10:06:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-oms-piu-dati-sui-vaccini-per-gestire-le-emergenze/ 2022-01-19T11:03:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-arriva-in-italia-adakveo-per-lanemia-falciforme/ 2022-01-19T13:17:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-msd-accordo-con-unicef-per-fornitura-molnupiravir/ 2022-01-19T13:55:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-rifiuta-offerta-unilever-da-68-mld-di-dollari-per-unita-farmaci-da-banco/ 2022-01-19T14:09:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-valneva-da-primi-studi-vaccino-efficace-contro-omicron/ 2022-01-20T10:17:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-primo-report-hta-su-malattia-meningococcica-da-sierogruppi-acwy/ 2022-01-20T10:37:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gavi-alliance-necessari-altri-5-mld-di-dollari-per-garantire-lapprovvigionamento-dei-vaccini-anti-covid/ 2022-01-20T11:02:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-crescono-i-ricavi-italia-al-quarto-posto-per-fatturato/ 2022-01-20T16:17:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-pronta-a-lanciare-wegovy-obesita/ 2022-01-20T14:07:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-nella-corsa-alla-cura-ce-anche-djokovic/ 2022-01-20T14:39:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roberta-busticchi-nominata-presidente-e-amministratore-delegato-di-siemens-healthcare-srl/ 2022-01-20T17:16:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicina-digitale-joint-venture-tra-polifarma-davinci-digital-therapeutics-e-davi-digitalmedicine/ 2022-01-21T10:06:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-in-studio-italo-russo-sputnik-v-piu-efficace-di-pfizer-contro-omicron/ 2022-01-21T10:31:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-le-strategie-per-ampliare-le-indicazioni-di-imfinzi/ 2022-01-23T15:49:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-partnership-con-fvg-per-polo-scienze-della-vita/ 2022-01-21T15:42:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ministri-salute-ue-pronti-per-eventuale-quarta-dose-vaccino-covid/ 2022-01-24T10:01:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-e-vir-biotechnology-gli-usa-acquistano-altre-600-mila-dosi-di-sotrovimab/ 2022-01-24T10:32:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-la-sfida-del-marketing-si-gioca-nel-real-world/ 2022-01-24T14:08:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-deloitte-roi-ai-livelli-piu-alti-dal-2014/ 2022-01-24T14:27:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bourla-ceo-pfizer-lavoriamo-a-un-vaccino-a-somministrazione-annuale/ 2022-01-24T15:45:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-pharma-italy-aifa-approva-rimborsabilita-di-ravulizumab/ 2022-01-25T17:48:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-la-nota-100-amplia-la-possibilita-di-prescrizione-degli-antidiabetici-ai-medici-di-medicina-generale-e-agli-specialisti/ 2022-01-26T16:36:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/galapagos-il-nuovo-ceo-e-un-ex-j/ 2022-01-27T10:27:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-via-alla-sperimentazione-del-booster-specifico-contro-omicron/ 2022-01-27T10:45:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-abbott-supera-le-stime-di-vendita-nel-q4-2021/ 2022-01-27T11:04:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-doctolib-italia-acquisisce-appocrate/ 2022-01-27T12:16:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-sale-lebitda-grazie-alla-domanda-componenti-vaccini/ 2022-01-27T13:54:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-fda-rivede-autorizzazione-alluso-in-emergenza-delle-terapie-di-regeneron-ed-eli-lilly/ 2022-01-27T15:58:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-da-chmp-dellema-via-libera-a-paxlovid/ 2022-01-27T15:27:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ad-anagni-si-produrra-il-nuovo-vaccino-anti-covid-in-sperimentazione/ 2022-01-28T10:45:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-informatori-sempre-piu-influencer/ 2022-01-31T08:27:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-nuovi-studi-su-aduhelm/ 2022-01-28T14:38:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-moderna-e-johnson-la-vaccinazione-booster-eterologa-e-meglio/ 2022-01-28T14:57:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-paxlovid-disponibile-dalla-prima-settimana-di-febbraio/ 2022-01-30T16:36:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-si-sperimenta-un-booster-proteico-per-via-intranasale/ 2022-01-31T11:16:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-biogen-esce-da-samsung-bioepis/ 2022-01-31T13:25:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/per-clinici-e-manager-e-ora-di-pensare-anche-ai-pazienti-no-covid-le-riflessioni-nel-primo-sanitalk-dellanno/ 2022-01-31T14:35:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-la-sfida-della-distribuzione-nellepoca-del-booster/ 2022-01-31T15:36:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-e-sanofi-stop-a-richiesta-aifa-per-estensione-dellantitumorale-libtayo/ 2022-01-31T15:53:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assosalute-mercato-otc-e-sop-in-ripresa-dopo-flessione-2020/ 2022-01-31T16:33:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-omicron-ce-una-sottovariante-piu-trasmissibile-delloriginale/ 2022-02-01T16:31:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-pfizer-biontech-pronte-a-chiedere-a-fda-lok-a-vaccino-nei-bambini-sotto-i-cinque-anni/ 2022-02-01T10:31:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/se-lopinion-leader-lo-sceglie-lai/ 2022-02-01T16:27:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-novavax-chiede-lautorizzazione-a-fda/ 2022-02-01T14:25:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nel-2021-crescita-a-una-singola-cifra-media/ 2022-02-02T10:23:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-chiara-giorgi-nuova-strategy-and-operations-head/ 2022-02-02T16:04:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-eli-lilly-ok-chmp-a-empagliflozin-nello-scompenso-cardiaco-cronico-sintomatico/ 2022-02-02T17:19:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-investe-in-un-nuovo-stabilimento-in-irlanda/ 2022-02-02T13:42:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-via-libera-chmp-a-dupilumab-per-i-bambini-tra-i-6-e-gli-11-anni-con-asma-grave-caratterizzato-da-uninfiammazione-di-tipo-2/ 2022-02-02T16:15:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/unicef-e-lilly-insieme-per-migliorare-la-salute-di-10-milioni-di-bambini-e-adolescenti/ 2022-02-02T17:15:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valneva-2022-a-gonfie-vele-con-il-vaccino-anti-covid/ 2022-02-03T10:15:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-crescita-a-due-cifre-dellutile-operativo/ 2022-02-03T10:43:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-si-allunga-la-lista-delle-societa-interessate/ 2022-02-03T11:06:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-i-numeri-del-2021-e-le-previsioni-per-il-2022/ 2022-02-03T11:59:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-nutraceutico-cosmony-anche-in-italia/ 2022-05-20T11:14:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-con-variante-omicron-impennata-di-vendite-per-remdesivir/ 2022-02-03T14:01:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-botox-e-skyrizi-fanno-aumentare-le-stime-di-profitto-per-il-2022/ 2022-02-04T10:36:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-aumento-degli-utili-legato-ad-approvazione-vaccino-covid/ 2022-02-04T14:29:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-2022-allinsegna-di-molnupiravir/ 2022-02-04T14:16:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-rinvia-application-fda-per-donanemab-alzheimer/ 2022-02-04T14:50:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dermatologia-lappello-dei-clinici-ad-agenda-2030-non-consideratele-malattie-di-minore-importanza/ 2022-02-07T09:24:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-q4-2021-oltre-le-aspettative/ 2022-02-07T10:21:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-smart-tv-una-nuova-frontiera-per-il-marketing/ 2022-02-07T13:33:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-q4-2021-oltre-le-attese/ 2022-02-07T13:52:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-ancora-problemi-per-aduhelm/ 2022-02-07T14:58:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-la-pressione-sui-prezzi-fa-calare-le-vendite/ 2022-02-08T10:09:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-fda-a-sutimlimab-jome-anemia-emolitica-autoimmune-da-agglutinine-fredde/ 2022-02-08T12:04:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-cybersicurezza-vulnerabilita-in-aumento/ 2022-02-08T14:15:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-tsunami-covid-sui-servizi-sanitari-di-base/ 2022-02-08T15:08:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-nel-2022-oltre-54-mld-di-dollari-da-vaccino-e-paxlovid/ 2022-02-09T10:31:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-impennata-di-vendite-per-sotrovimab/ 2022-02-09T10:51:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vik-un-assistente-virtuale-per-le-donne-con-tumore-ovarico/ 2022-02-09T11:32:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-via-alla-revisione-per-dose-booster-nella-fascia-di-eta-1215anni/ 2022-02-09T17:00:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-vendite-in-crescita-nel-2022/ 2022-02-10T09:45:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vir-biotechnology-sotrovimab-efficace-contro-la-sottovariante-di-omicron/ 2022-02-10T10:39:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-un-premio-per-la-ricerca-scientifica-senza-divario-di-genere/ 2022-02-10T11:09:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-arriva-in-italia-risdiplam-il-primo-farmaco-per-il-trattamento-a-domicilio-della-sma/ 2022-02-10T11:59:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-angelini-pharma-sentenza-del-consiglio-di-stato-fa-chiarezza-su-uso-paracetamolo/ 2022-02-10T13:48:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-nasce-darwin-centro-di-raccolta-dati-real-world/ 2022-02-10T14:41:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-al-via-a-roma-progetto-dinformazione-per-le-scuole-superiori-contro-lo-stigma-e-le-fake-news/ 2022-03-24T07:30:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bourla-ceo-pfizer-continueremo-a-crescere-per-tutto-il-decennio/ 2022-02-11T09:31:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-limportanza-dellinclusivita-nel-marketing/ 2022-02-11T11:36:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-vaccino-anti-covid-efficace-negli-adolescenti/ 2022-02-11T13:53:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/next-generation-sequencing-12-steps-per-realizzarlo/ 2022-02-13T16:46:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-lancia-bymyepilepside-campagna-di-informazione-sullepilessia/ 2022-02-14T09:53:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dermatologia-peris-sidemast-dopo-covid-atteso-boom-malattie-trascurate-non-facciamoci-trovare-impreparati/ 2022-02-14T10:22:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-remdesivir-e-efficace-anche-contro-la-nuova-sottovariante-di-omicron/ 2022-02-14T10:33:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-ok-fda-a-bebtelovimab-nel-covid/ 2022-02-14T10:55:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-italia-alessandro-cappiello-nuovo-country-leader/ 2022-02-14T12:06:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-e-il-lancio-lento-di-tirzepatide/ 2022-02-14T16:10:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aderenza-alle-terapie-come-controllarla/ 2022-02-15T15:56:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-punta-sul-triangolo-doro-del-regno-unito-per-la-produzione/ 2022-02-15T16:02:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-traina-la-ripresa-ma-fatica-in-borsa/ 2022-02-15T16:17:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmacie-rapporto-iqvia-il-2021-e-lanno-del-ripresa-fatturato-in-crescita/ 2022-02-15T16:29:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riforma-irccs-il-cdm-approva-il-disegno-di-legge-delega-al-governo/ 2022-02-15T16:41:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-accordo-decennale-con-rovi-per-produzione-farmaci-con-tecnologia-mrna/ 2022-02-16T10:12:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2022-tornano-le-grandi-fusioni/ 2022-02-16T14:24:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brand-reputation-come-conservarla-dopo-un-accordo-di-fusione/ 2022-02-16T15:43:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-al-seno-la-terapia-di-gruppo-per-la-salute-mentale/ 2022-02-16T16:01:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-vaccino-contro-omicron-e-in-ritardo/ 2022-02-17T14:37:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-attenzione-alla-stanchezza-da-promozione/ 2022-02-17T14:38:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bancel-ceo-moderna-booster-per-omicron-pronto-entro-agosto/ 2022-02-17T14:37:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dispositivi-medici-cala-la-produzione-made-in-italy/ 2022-02-17T15:08:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-luci-accese-sulla-fibromialgia/ 2022-02-18T10:14:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/califf-fda-priorita-alla-lotta-contro-la-disinformazione-scientifica/ 2022-02-18T10:58:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/addio-a-marino-golinelli-fondatore-di-alfasigma/ 2022-02-21T14:56:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ma-uno-sguardo-al-mercato-cinese/ 2022-02-20T14:27:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-pronta-a-sviluppare-vaccino-a-mrna-contro-lherpes-zoster/ 2022-02-21T11:15:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-lancia-in-europa-generico-di-revlimid/ 2022-02-21T11:35:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aim-in-italia-e-necessaria-una-definizione-normativa-di-medicinale-di-importazione-parallela/ 2022-02-21T15:14:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-a-maggio-nuovo-presidente/ 2022-02-21T15:47:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-per-trastuzumab-deruxtecan-nuove-positive-evidenze-dallo-studio-destiny-breast04/ 2022-02-22T10:11:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/smith-nephew-nuovo-ceo-per-il-rilancio-dopo-la-pandemia/ 2022-02-22T11:02:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-utili-in-crescita-per-il-2022/ 2022-02-22T11:17:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-obiettivo-trasformazione-nel-campo-della-salute/ 2022-02-22T12:10:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-cina-leadership-cercasi/ 2022-02-22T15:40:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/i/ 2022-02-22T17:52:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-al-via-studio-di-fase-avanzata-su-vaccino-mrna-per-rsv/ 2022-02-23T10:17:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-aumento-dei-profitti-con-ripresa-interventi-chirurgici/ 2022-02-23T12:49:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-futuro-radioso-per-inclisiran/ 2022-02-23T13:20:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-le-nuove-sfide-della-logistica/ 2022-02-23T14:40:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-gsk-pronte-a-chiedere-lautorizzazione-per-il-vaccino-covid19/ 2022-02-23T17:16:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-delle-malattie-rare-limpegno-di-takeda-italia/ 2022-02-24T10:35:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-inizia-a-spedire-il-vaccino-anti-covid-nella-ue/ 2022-02-24T10:58:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-accordo-con-thermo-fisher-per-farmaci-a-tecnologia-mrna/ 2022-02-24T11:17:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lavanzata-della-pubblicita-digitale/ 2022-02-24T15:34:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-oms-punta-a-secondo-hub-di-trasferimento-tecnologico-per-paesi-a-basso-e-medio-reddito/ 2022-02-24T15:49:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-moderna-chmp-dellema-raccomanda-approvazione-per-i-bambini-dai-6-agli-11-anni/ 2022-02-24T16:05:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-pfizer-lema-favorevole-a-dose-booster-per-gli-over-12/ 2022-02-24T16:45:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-quarta-dose-vaccino-covid-entro-la-fine-dellanno/ 2022-02-25T10:04:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/raise-the-patients-voice-associazioni-pazienti-sempre-piu-al-centro-della-sanita-del-futuro/ 2022-02-25T13:32:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pnrr-per-i-manager-senza-assunzioni-rischia-di-essere-una-ferrari-senza-pilota/ 2022-02-25T16:39:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cosa-pensano-i-pazienti-dei-loro-farmaci-lo-dice-una-piattaforma/ 2022-02-27T16:00:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/global-innovators-2022-nella-top-100-jj-philips-e-roche/ 2022-02-28T10:23:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-intervallo-tra-seconda-e-terza-dose-del-vaccino-moderna-da-sei-a-tre-mesi/ 2022-02-28T10:42:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-pfizer-chiedera-il-voto-degli-azionisti-su-strategia-di-prezzo-e-condivisione-della-tecnologia/ 2022-02-28T13:59:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-aifa-nei-primi-10-mesi-del-2021-ospedaliera-supera-il-tetto-di-16-miliardi/ 2022-02-28T14:37:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-accordo-con-neurimmune-per-sviluppo-anticorpo-monoclonale-in-cardiologia/ 2022-03-01T14:04:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-dal-vaccino-fatturato-atteso-tra-i-4-e-i-5-mld-di-dollari/ 2022-03-01T10:35:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-da-fda-revisione-prioritaria-per-opdivo-e-chemio-come-strategia-neoadiuvante-contro-il-nsclc/ 2022-03-01T13:26:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-ok-della-fda-a-carvykti-terapia-cart-di-jj-e-legend/ 2022-03-01T16:39:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/neopharmed-gentili-acquisisce-da-bayer-i-diritti-dei-prodotti-a-base-di-lormetazepam/ 2022-03-01T15:42:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-per-la-ricerca-clinica-bando-da-300-mila-euro-per-10-progetti-innovativi/ 2022-03-01T17:17:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sangue-e-plasma-per-clinici-e-associazioni-la-donazione-deve-restare-volontaria-ma-il-sistema-va-potenziato/ 2022-03-02T10:39:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/curevac-lancia-la-sussidiaria-rna-printer-per-servizi-end-to-end-alle-aziende-clienti/ 2022-03-02T11:03:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-cede-unita-biosimilari-a-biocon-biologics/ 2022-03-02T11:22:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ancora-unevidenza-per-dupilumab/ 2022-03-02T14:12:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-e-lo-stigma-limpegno-di-viiv-healthcare-con-la-campagna-takle-hiv/ 2022-03-03T10:39:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-italia-al-via-il-sabato-della-salute-con-linrc/ 2022-03-03T11:18:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-in-italia-i-risultati-dello-screening-save-your-heart/ 2022-03-03T12:07:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-niservimab-raggiunge-endpoint-primario-nella-protezione-da-rsv/ 2022-03-03T15:19:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-ok-oms-a-molnupiravir-msd-nei-pazienti-a-rischio/ 2022-03-03T16:40:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-croniche-usa-strumento-interattivo-valuta-costi-e-diffusione/ 2022-03-03T16:02:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-raddoppia-target-di-vendita-farmaci-contro-lobesita/ 2022-03-04T10:42:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-investe-14-miliardi-in-stabilimenti-in-germania/ 2022-03-04T14:28:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/guerra-in-ucraina-big-pharma-con-le-organizzazioni-umanitarie/ 2022-03-04T15:08:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-100-mila-confezioni-di-farmaci-per-la-popolazione-ucraina/ 2022-03-04T17:06:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-fda-estende-indicazione-duso-per-opdivo/ 2022-03-07T10:30:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-dermatite-atopica-grave-ok-aifa-a-rimborsabilita-dupilumab-nel-trattamento-dei-bambini-tra-6-e-11anni/ 2022-03-07T11:57:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dermatologia-clinici-contro-depauperamento-della-branca-invertiamo-la-rotta/ 2022-03-07T14:00:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-partnership-con-honeywell-per-sviluppare-inalatori-respiratori-di-nuova-generazione/ 2022-03-07T14:23:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/generazioni-dei-dati-una-possibilita-per-il-medical-affairs/ 2022-03-07T17:01:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-entro-il-2025-15-nuovi-vaccini/ 2022-03-08T14:48:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-sette-attacchi-a-strutture-sanitarie-dallinizio-del-conflitto-in-ucraina/ 2022-03-08T14:45:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/24113/ 2022-03-08T15:09:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-ripartire-da-donne-welfare-ricerca-e-giovani-per-dare-nuova-energia-al-paese-e-favorire-la-natalita/ 2022-03-08T16:36:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/reputazione-pharma-effetto-lockdown-per-la-stampa-mainstream/ 2022-03-09T14:17:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-farmaco-contro-angioedema-promettente-nel-trattamento-di-covid19/ 2022-03-09T16:54:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-cdc-negli-usa-emerge-la-sottovariante-ba2-di-omicron/ 2022-03-09T14:49:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/consiglio-superiore-di-sanita-franco-locatelli-confermato-alla-presidenza/ 2022-03-09T17:16:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/psoriasi-in-italia-molti-pazienti-non-vengono-trattati-secondo-le-linee-guida/ 2022-03-10T09:03:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-emofilia-a-efmoroctocog-alfa-farmaco-vantaggioso-per-il-paziente-e-per-il-sistema-sanitario/ 2022-03-10T11:04:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-tra-le-aziende-piu-impegnate-nella-sostenibilita/ 2022-03-10T14:00:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-via-allo-studio-su-paxlovid-nei-bambini-617-anni/ 2022-03-10T14:21:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-2021-anno-dei-record-in-ricerca-e-sviluppo/ 2022-03-10T17:26:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-rapporto-antibiotici-2020-italia-ancora-lontana-dal-target-oms/ 2022-03-10T15:46:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-al-gemelli-di-roma-primo-intervento-in-europa-con-il-robot-hugo/ 2022-03-11T17:23:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/crisi-ucraina-le-big-pharma-non-interromperanno-la-fornitura-di-farmaci-alla-russia/ 2022-03-11T14:29:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-produrra-a-contratto-terapie-car-m/ 2022-03-11T14:49:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-completa-lespansione-in-cina/ 2022-03-11T15:04:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-completa-lacquisizione-di-zogenix/ 2022-03-14T10:25:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-al-via-il-secondo-ciclo-di-digital-talk-roche-now-connessi-per-la-salute-del-futuro/ 2022-03-14T13:53:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-flop-novavax/ 2022-03-14T14:09:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valneva-attesa-per-aprile-approvazione-vaccino-covid/ 2022-03-14T14:20:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/guerra-in-ucraina-limpatto-sugli-studi-clinici/ 2022-03-14T15:22:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-studio-sullimpatto-economico-delle-malattie-rare-negli-usa/ 2022-03-15T10:58:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-e-sifo-firmato-protocollo-dintesa/ 2022-03-15T11:08:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/doctolib-round-di-finanziamenti-di-500-milioni-di-euro-per-la-digitalizzazione-della-sanita/ 2022-03-15T11:39:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-acquisisce-coalesce-azienda-britannica-attiva-nel-settore-respiratorio/ 2022-03-15T14:59:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-completa-lacquisizione-di-eusa-pharma/ 2022-03-17T09:25:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-gilead-ok-aifa-a-terapia-car-t-per-linfoma-a-cellule-mantellari-recidivante-o-refrattario/ 2022-03-17T17:22:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-collaborazione-con-il-mit-nel-settore-dei-dispositivi-di-erogazione-dei-farmaci/ 2022-03-17T17:50:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-pfizer-e-biontech-chiederanno-alla-fda-ok-alla-quarta-dose/ 2022-03-17T18:03:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/unmet-medical-need-ue-allineare-le-diverse-interpretazioni/ 2022-03-17T14:48:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trionfo-di-personalita-ai-life-science-excellence-awards-2021/ 2022-03-23T11:25:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/patient-support-program-quando-ospedali-e-terapie-non-sono-lunico-modo-per-curare-i-pazienti/ 2022-03-24T07:20:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-pubblicati-i-dati-di-fase-3-su-aducanumab/ 2022-03-18T13:41:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-anche-moderna-chiede-a-fda-ok-per-la-seconda-dose-di-richiamo/ 2022-03-18T13:55:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-tra-aprile-e-luglio-i-dati-sui-vaccini-anti-omicron/ 2022-03-18T14:13:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-nintedanib-pf-ild-ottiene-rimborsabilita-in-fascia-h/ 2022-03-18T15:59:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-evusheld-neutralizza-le-sottovarianti-di-omicron/ 2022-03-21T11:38:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-cybersecurity-aumentano-le-violazioni-dei-dati/ 2022-03-21T16:56:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-innovative-per-le-aziende-farmaceutiche-bisogna-imparare-a-guardare-lontano/ 2022-03-24T07:19:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ok-a-relatlimab-nel-melanoma-avanzato/ 2022-03-21T16:43:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-reputation-in-discesa-ma-ancora-sopra-i-livelli-pre-pandemia/ 2022-03-21T15:22:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nuovo-volto-del-pharma-la-rivoluzione-delle-biotech/ 2022-03-24T07:19:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-cresce-il-mercato-dei-farmaci-branded/ 2022-03-22T13:46:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-lorraine-nolan-e-la-nuova-presidente-del-consiglio-di-amministrazione/ 2022-03-22T14:02:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-la-ricerca-in-italia-modelli-di-collaborazione-pubblico-privato/ 2022-03-22T14:18:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-i-tumori-del-sangue-leccellenza-italiana/ 2022-03-22T14:19:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-su-cosa-puntera-il-marketing-nei-prossimi-12-mesi/ 2022-03-22T15:24:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tecnologia-e-sanita-il-ruolo-delle-aziende-per-rendere-il-futuro-una-grande-opportunita/ 2022-03-24T07:19:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-mappa-strategie-per-migliorare-la-qualita-dei-prodotti-farmaceutici/ 2022-03-23T13:33:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-nasce-la-start-up-specializzata-aerium-therapeutics-il-ceo-e-un-ex-takeda/ 2022-03-23T14:00:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-pronta-a-chiedere-ok-alluso-del-suo-vaccino-covid19-per-i-bambini-sotto-i-6-anni/ 2022-03-23T17:08:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-eahp-sifo-pronti-a-raccogliere-la-sfida-della-value-based-healthcare/ 2022-03-24T10:21:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-fda-a-terapia-contro-il-cancro-della-prostata/ 2022-03-24T10:41:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-aifa-necessari-ulteriori-approfondimenti-su-secondo-booster-vaccini/ 2022-03-24T14:10:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-sanofi-e-gsk-pronte-a-chiedere-lok-per-il-vaccino/ 2022-03-24T16:18:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-futuro-della-sanita-e-non-solo-e-one-health/ 2022-03-25T10:05:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-due-progetti-per-le-health/ 2022-03-25T10:38:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-investira-nella-supply-chain/ 2022-03-25T11:02:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-cure-del-futuro-fra-tecnologia-genetica-e-terapie-digitali/ 2022-03-25T11:02:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-ok-ema-a-terapia-cart-contro-il-mieloma-multiplo/ 2022-03-29T09:18:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-per-dupixent-picchi-di-vendite-fino-a-13-miliardi-di-euro/ 2022-03-29T09:31:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pnrr-una-riforma-che-va-ben-oltre-il-mattone-le-riflessioni-a-camerae-sanitatis/ 2022-03-29T13:40:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prevenzione-covid-19-ema-approva-combinazione-anticorpi-astrazeneca/ 2022-03-29T09:39:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-in-5-anni-investimenti-per-275-milioni-di-euro/ 2022-03-29T12:31:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/censis-janssen-italia-come-sara-la-sanita-italiana-post-covid/ 2022-03-29T13:30:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-ema-avvia-revisione-in-tempo-reale-del-vaccino-proteico-di-hipra/ 2022-03-30T09:06:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ma-in-sanita-nel-2021-boom-di-operazioni/ 2022-03-30T09:45:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-ok-fda-a-seconda-dose-booster-per-over-50-e-immunodepressi/ 2022-03-30T12:46:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/artrite-reumatoide-revisione-della-letteratura-identifica-risparmi-generati-dalla-remissione-clinica-di-malattia/ 2022-03-30T12:54:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-bene-etrasimod-colite-ulcerosa-in-studio-di-fase-avanzata/ 2022-03-30T13:39:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-obbligazioni-per-15-miliardi-di-euro-legate-allaccesso-ai-farmaci/ 2022-03-31T09:26:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-biontech-investe-su-sperimentazioni-contro-omicron/ 2022-03-31T12:23:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-farmaceutico-2019-2020-saldato-dalle-aziende-il-98-di-quanto-dovuto/ 2022-03-31T13:14:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofigsk-allema-la-domanda-di-approvazione-del-vaccino-anti-covid19/ 2022-03-31T13:39:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-2021-in-crescita-europa-mercato-principale/ 2022-04-01T09:15:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-la-gestione-delle-persone-con-sclerosi-multipla-nel-post-pandemia/ 2022-04-01T09:22:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pnrr-la-vera-sfida-del-territorio-e-curare-il-paziente-a-casa/ 2022-04-01T09:35:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-2-mld-di-dollari-per-siti-produzione-terapie-geniche-e-cellulari/ 2022-04-01T13:00:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-limpatto-delle-terapie-con-plasmaderivati-in-europa-soluzioni-per-litalia/ 2022-04-01T16:47:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-italia-il-nuovo-managing-director-e-alessandro-lattuada/ 2022-04-04T13:16:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dedalus-group-massimo-angileri-nominato-general-manager-italia/ 2022-04-04T09:50:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuovo-modello-operativo-per-risparmiare-1mld-di-dollari/ 2022-04-04T13:15:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-gilead-ok-fda-a-yescarta-in-seconda-linea-nel-linfoma-a-grandi-cellule-b/ 2022-04-04T13:33:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ha-prodotto-6-milioni-di-cicli-completi-di-paxlovid/ 2022-04-05T09:18:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-bene-ocrevus-dopo-un-anno-di-trattamento/ 2022-04-05T09:30:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovi-antibiotici-fondo-usa-investe-in-due-start-up/ 2022-04-05T12:46:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-italia-da-aprile-novita-nel-lavoro-meta-mese-in-smart-working/ 2022-04-05T13:12:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-metaverso-opportunita-per-il-marketing-pharma/ 2022-04-05T13:39:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-a-padova-la-campagna-blood-artists-per-sensibilizzare-sullanemia-falciforme-e-la-talassemia/ 2022-04-05T14:52:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/24413/ 2022-04-05T15:52:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-2021-trainato-da-jardiance-e-dai-farmaci-veterinari/ 2022-04-06T09:33:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-arriva-in-italia-rybelsus-diabete/ 2022-04-06T16:22:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/web3-le-possibilita-per-il-settore-farmaceutico-e-biotech/ 2022-04-06T12:56:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-aifa-a-rimborsabilita-isatuximab/ 2022-04-06T13:47:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-italia-arriva-la-tripla-associazione-fissa-in-formulazione-extrafine-per-la-bpco/ 2022-04-06T16:17:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ripensare-i-vaccini-covid-contro-le-future-varianti-la-risposta-a-giugno/ 2022-04-07T09:42:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jansen-italia-progetto-fattore-j-4-giovani-su-5-si-fidano-di-scienze-e-istituzioni-sanitarie/ 2022-04-07T13:15:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-e-ecdc-non-ci-sono-prove-a-sostegno-della-quarta-dose-del-vaccino-covid/ 2022-04-07T13:45:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-programma-globale-di-partnership-per-sconfiggere-laids/ 2022-04-07T16:12:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-rafforza-la-linea-di-farmaci-respiratori-con-lacquisizione-di-reviral/ 2022-04-08T09:37:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-aifa-approva-la-rimborsabilita-di-creonipe-35-000/ 2022-04-11T10:48:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pnrr-tecnologie-partnership-di-valore-takeda-pronta-a-raccogliere-le-nuove-sfide-intervista-a-luca-gentile-public-affairs-patient-advocacy-communications-director-di-takeda-italia/ 2022-04-11T14:20:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beckman-coulter-ottiene-il-marchio-ce-per-lapplicazione-mdw-sars-cov-2/ 2022-04-11T14:21:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-cipomo-e-sda-bocconi-puntano-sui-giovani-talenti-formati-i-dirigenti-di-domani/ 2022-04-11T14:24:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-nel-medical-affairs-funzionano-i-meeting-virtuali/ 2022-04-11T14:25:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-e-abbvie-chiuderanno-bene-il-decennio-le-previsioni-di-morgan-stanley/ 2022-04-11T14:26:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-nomina-jorge-gomez-nuovo-cfo/ 2022-04-12T16:05:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/loms-monitora-due-nuove-sottovarianti-di-omicron/ 2022-04-12T10:10:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-al-via-una-campagna-di-sensibilizzazione-sullasma/ 2022-04-12T10:44:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-con-aaa-ascoltiamo-laderenza-per-la-giornata-nazionale-per-laderenza-alla-terapia/ 2022-04-12T12:42:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-la-campagna-mielo-spieghi-per-informare-sulle-neoplasie-mieloproliferative-croniche/ 2022-04-12T12:59:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/veeva-armando-inserra-nuovo-head-of-commercial-business-per-litalia/ 2022-04-12T13:43:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-in-italia-50-anni-di-storia/ 2022-04-13T06:42:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-le-sfide-del-territorio-per-la-presa-in-carico-della-cronicita-prospettive-di-intervento-e-parametri-di-qualita/ 2022-04-13T09:47:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-acquisisce-sierra-oncology/ 2022-04-13T15:01:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-accordo-con-matinas-biopharma-per-vaccini-a-mrna-orali/ 2022-04-13T13:00:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-in-arrivo-un-nuovo-cfo-david-denton-esperto-in-ma/ 2022-04-14T12:52:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-presto-un-protocollo-di-gestione-di-qualita/ 2022-04-14T13:14:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hta-in-europa-comincia-la-fase-operativa/ 2022-04-14T15:38:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-aifa-tra-gennaio-e-novembre-2021-ospedaliera-sfora-di-quasi-2-miliardi-la-convenzionata-si-conferma-sotto-il-tetto/ 2022-04-14T14:42:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-nel-2022-vendite-in-linea-con-il-2021/ 2022-04-15T10:04:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-buoni-dati-dose-booster-contro-omicron-nella-fascia-5-11-anni/ 2022-04-15T13:22:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-ok-ce-a-dupilumab-per-bambini-dai-6-agli-11-anni-con-asma-grave-causato-da-infiammazione-di-tipo-2/ 2022-04-19T11:11:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-entro-fine-aprile-eua-alla-fda-per-vaccino-covid-a-bambini-tra-i-sei-mesi-e-i-cinque-anni/ 2022-04-21T09:18:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-laboratories-utile-del-q1-sale-del-36/ 2022-04-21T09:57:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-precisazioni-su-paracetamolo-e-vigile-attesa/ 2022-04-21T12:02:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/j-annulla-le-stime-di-vendita-del-vaccino-contro-il-covid/ 2022-04-21T13:24:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-per-paxlovid-offerta-supera-la-domanda/ 2022-04-21T14:00:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-aifa-approva-rimborsabilita-per-ofatumumab-di-novartis/ 2022-04-21T14:42:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-andrea-celli-diventa-managing-director-di-italia-israele-e-grecia/ 2022-04-21T14:43:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-e-fujifilm-italia-partnership-con-fitprime-per-la-prevenzione-del-tumore-al-seno/ 2022-04-21T15:43:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-oms-raccomanda-paxlovid-per-i-pazienti-ad-alto-rischio/ 2022-04-22T09:19:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-per-analisti-prematuro-ipotizzare-una-riduzione-della-domanda-nel-2022/ 2022-04-22T12:49:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-ivosidenib-in-combinazione-con-azacitidina-aumenta-la-sopravvivenza-complessiva-nella-lma/ 2022-04-25T08:04:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-buoni-risultati-da-combo-vaccino-covid-influenza/ 2022-04-25T08:35:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-q1-in-crescendo-grazie-alle-vendite-di-cosentyx-e-di-entresto/ 2022-04-26T09:18:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-ok-fda-a-impiego-remdesivir-nei-neonati/ 2022-04-26T09:30:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-lancia-la-campagna-dermatite-atopica-rimettiti-in-gioco/ 2022-04-26T15:51:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-aumentano-del-10-le-vendite-nel-q1/ 2022-04-26T13:37:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-ema-raccomanda-dose-booster-con-pfizerbiontech/ 2022-04-26T15:00:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/camera-dei-deputati-presentata-proposta-di-legge-sulla-prevenzione-del-melanoma-cutaneo/ 2022-04-27T09:14:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-inaugura-la-nuova-sede-in-mind-milano-innovation-district/ 2022-04-27T12:55:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-q1-oltre-le-aspettative/ 2022-04-27T13:26:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ceo-chi-si-fida-di-loro/ 2022-04-27T14:15:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-marketing-per-operatori-sanitari-poche-mail-e-di-alta-qualita/ 2022-04-27T14:42:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-dupixent-porta-in-alto-il-q1/ 2022-04-28T09:36:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizerbiohaven-ok-ce-ad-antiemicranico-rimegepant/ 2022-04-28T12:40:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-il-vaccino-shingrix-dietro-il-successo-del-q1/ 2022-04-28T12:58:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-fino-all80-della-popolazione-dellunione-ha-contratto-il-covid/ 2022-04-28T14:57:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-in-crescita-i-ricavi-nel-q1/ 2022-04-29T10:08:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-q1-con-aumenti-di-profitti-e-vendite/ 2022-04-29T10:24:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuovi-dati-importanti-per-risdiplam-dallo-studio-firefish-sma-pediatrica-di-tipo-1/ 2022-04-29T13:05:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-da-fda-breakthrough-therapy-per-trastuzumab-deruxtecan-nel-carcinoma-mammario-non-resecabile-o-metastatico-a-bassa-espressione-di-her2/ 2022-04-29T13:55:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovo-dm-70-allarme-della-sidemast-pazienti-dermatologici-senza-assistenza-se-il-testo-non-cambia/ 2022-04-29T14:42:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pnrr-sia-anche-il-tempo-delle-cronicita-misconosciute-le-riflessioni-a-sanitask/ 2022-05-03T09:01:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-covid19-paxlovid-non-previene-linfezione-nei-familiari-conviventi/ 2022-05-03T09:53:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipertensione-arteriosa-polmonare-chiesi-acquisisce-il-portafoglio-di-mab-contro-emap/ 2022-05-03T12:29:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/app-esprimiti-la-voce-dei-sintomi-invisibili-della-sclerosi-multipla/ 2022-05-03T12:29:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-un-piano-per-risparmiare-su-costi-ed-esami-inutili/ 2022-05-03T15:04:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/screening-mammografico-ladesione-migliora-con-strumenti-piu-efficaci-bayer-a-fianco-di-europa-donna/ 2022-05-03T15:29:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/quando-la-farmaceutica-sposa-larte-menarini-presenta-la-monografia-di-raffaello/ 2022-05-09T14:41:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congiuntivite-stagionale-allergica-da-alcon-federasma-e-allergie-odv-un-decalogo-per-il-farmacista/ 2022-05-09T14:43:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanita-landazabal-gsk-dopo-pandemia-settore-verso-rivoluzione-digitale/ 2022-05-09T15:17:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-e-aism-presentano-the-willchair-la-sedia-di-design-simbolo-di-un-futuro-oltre-i-limiti-della-sclerosi-multipla/ 2022-05-09T14:45:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-cala-nel-q1-lutile-netto-ma-obiettivi-2022-confermati/ 2022-05-10T09:38:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fidia-nuovo-sito-web-per-nuovo-posizionamento/ 2022-05-16T14:58:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/studio-economist-impact-daiichi-sankyo-il-covid-19-aumenta-i-rischi-per-il-cuore/ 2022-05-10T12:41:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-ricavi-in-crescita-nel-q1-confermati-obiettivi-2022/ 2022-05-10T12:48:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-ce-a-tisagenlecleucel-come-prima-terapia-cellulare-cart-per-adulti-nel-linfoma-follicolare-recidivante-o-refrattario/ 2022-05-10T13:07:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-triplicati-utili-e-vendite-nel-q1/ 2022-05-10T14:07:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-nasce-eureking-la-prima-spac-europea/ 2022-05-10T14:39:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-barbara-capaccetti-nuovo-medical-regulatory-director/ 2022-05-10T15:26:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-seno-her2-metastatico-fda-approva-trattamento-daiichi-sankyoastrazeneca-per-donne-precedentemente-trattate-con-anti-her2/ 2022-05-10T15:06:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-cala-lutile-operativo-ma-le-previsioni-sono-positive/ 2022-05-11T09:12:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/logistica-interporto-di-livorno-hub-per-centro-italia/ 2022-05-11T09:46:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-acquisisce-biohaven-per-116-miliardi-di-dollari/ 2022-05-11T10:32:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nuovi-dati-consolidano-il-profilo-di-efficacia-di-nirsevimab-rsv/ 2022-05-11T11:06:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-gli-esperti-si-dividono-sullutilita-dei-test-di-massa/ 2022-05-11T13:35:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-e-pfizer-disponibile-in-italia-avelumab-nel-trattamento-di-mantenimento-di-prima-linea-del-carcinoma-uroteliale-localmente-avanzato-o-metastatico-senza-progressione-dopo-chemioterapia-a-base-d/ 2022-05-11T14:40:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-presentato-a-fda-dossier-per-vaccino-covid-a-bambini-e-adolescenti/ 2022-05-12T09:15:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-nuovo-ceo-per-la-bu-consumer-health-futuro-spin-off/ 2022-05-12T09:30:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sviluppo-farmaci-la-lezione-della-pandemia/ 2022-05-12T13:31:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ecco-i-vincitori-del-bando-research-to-care-oncohematology-edition/ 2022-05-12T13:51:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-dapagliflozin-raggiunge-endpoint-nello-studio-deliver-scompenso-cardiaco/ 2022-05-12T14:53:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-pharma-essere-green-non-basta-piu-la-sostenibilita-passa-anche-per-le-persone-leconomia-la-comunita/ 2022-05-12T16:16:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-lenacapavir-efficace-contro-lhiv-multiresistente/ 2022-05-13T09:22:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-con-niraparib-piu-di-due-anni-senza-progressione-del-tumore-ovarico/ 2022-05-13T09:47:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-definire-gli-obiettivi-per-sfruttare-al-meglio-i-dati/ 2022-05-13T13:20:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-biovac-prevede-calo-della-domanda-anche-in-africa/ 2022-05-13T14:28:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-torna-a-parlare-di-benessere-femminile-con-vagina-academy-20/ 2022-05-16T10:23:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-fda-approva-tirzepatide-diabete-tipo-2/ 2022-05-16T16:02:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valneva-guidance-2022-da-rivedere-senza-ok-ce-al-vaccino-contro-il-covid19/ 2022-05-16T16:02:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-in-europa-consegne-nel-quarto-trimestre-per-eventuale-nuova-campagna-vaccinale/ 2022-05-16T13:11:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-piani-per-migliorare-diagnosi-e-cure-nei-paesi-in-via-di-sviluppo/ 2022-05-16T14:38:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ad-astrazeneca-le-terapie-anti-covid-di-rq-bio/ 2022-05-17T10:20:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-stile-netflix-per-parlare-ai-reumatologi/ 2022-05-17T14:13:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-il-nuovo-inibitore-sperimentale-della-fosfodiesterasi-4b-rallenta-il-declino-della-funzione-polmonare-nei-soggetti-con-fibrosi-polmonare-idiopatica/ 2022-05-17T14:04:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ma-2021-fiacco-ma-sta-arrivando-la-ripresa/ 2022-05-17T14:23:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-resiste-mentalita-conservatrice-sui-lanci-dei-prodotti-digitali/ 2022-05-17T14:42:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibrance-pfizer-migliora-la-sopravvivenza-dei-pazienti-affetti-da-cancro-della-mammella/ 2022-05-18T09:29:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-negli-usa-luso-di-paxlovid-e-aumentato-di-oltre-il-300/ 2022-05-18T09:43:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/q1-2022-le-big-pharma-mantengono-la-crescita/ 2022-05-18T12:36:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-astrazeneca-estende-la-sua-partnership-con-proteros/ 2022-05-18T13:46:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-chiude-due-partnership-di-ricerca-sui-vaccini-con-bavarian-nordic/ 2022-05-18T15:44:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-ok-aifa-a-trifluridinatipiracil-per-il-trattamento-delle-fasi-avanzate-di-carcinoma-gastrico/ 2022-05-19T15:24:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/24800/ 2022-05-19T15:25:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-compie-40-anni-di-presenza-in-italia/ 2022-05-19T11:12:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-pubblicato-il-rapporto-di-sostenibilita-2021/ 2022-05-19T12:35:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/xxvi-congresso-cipomo-loncologia-va-riorganizzata-dal-pnrr-nuove-opportunita-ma-bisogna-fare-presto/ 2022-05-20T16:35:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-biologici-120-mld-di-dollari-in-piu-di-vendite-rispetto-alle-molecole-tradizionali-entro-il-2027/ 2022-05-19T13:28:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-i-vincitori-delledizione-2022/ 2022-06-24T12:50:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-da-ema-ok-a-dose-booster-del-vaccino-anti-covid/ 2022-05-20T08:56:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaiolo-delle-scimmie-prime-richieste-di-farmaci-a-siga-e-bavarian-nordic/ 2022-05-20T09:16:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-xxvi-congresso-cipomo-inserire-la-profilazione-molecolare-estesa-nei-lea/ 2022-05-20T10:46:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiotecfederchimica-fabrizio-greco-e-il-nuovo-presidente/ 2022-05-20T12:08:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/studi-clinici-scaccabarozzi-farmindustria-ogni-anno-investiti-oltre-700-milioni-in-italia-dalle-imprese-del-farmaco/ 2022-05-20T12:20:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-espande-collaborazione-con-bridgebio-pharma-in-ambito-oncologico/ 2022-05-20T12:50:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/xxvi-congresso-cipomo-in-oncologia-la-nuova-terapia-e-anche-la-gentilezza-ma-serve-una-leadership-aziendale-piu-attenta/ 2022-05-23T07:23:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-chmp-raccomanda-approvazione-commissione-europea-per-upadacitinib-per-la-colite-ulcerosa-attiva-da-moderata-a-grave/ 2022-05-23T12:13:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/galapagos-italia-alessandra-sinibaldi-e-la-nuova-value-market-accessgovernment-affairs-senior-director/ 2022-05-23T12:51:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-chmp-dellema-raccomanda-lapprovazione-di-olipudasi-alfa-per-lasmd/ 2022-05-23T14:37:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ptc-therapeutics-ok-del-chmp-dellema-a-terapia-genica-upstaza/ 2022-05-23T14:04:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibsa-farmaceutici-lancia-tre-nuovi-integratori-vitaminici/ 2022-05-23T14:56:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emicrania-per-6-mln-di-italiani-ma-il-reale-riconoscimento-della-malattia-appare-lontano-le-riflessioni-a-camerae-sanitatis/ 2022-05-23T15:43:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid-19-pfizer-biontech-buona-risposta-alla-terza-dose-nei-bambini-sotto-i-5-anni/ 2022-05-24T09:59:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-biosciences-italy-e-mylan-italia-programma-compassionevole-per-tafasitamab-in-associazione-con-lenalidomide-nel-dlbcl-in-italia/ 2022-05-24T10:15:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ue-approva-dose-booster-vaccino-anti-covid/ 2022-05-24T16:01:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-stop-ad-accordo-su-cart-con-atara-biotherapeutics/ 2022-05-24T10:49:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/wef-davos-booster-da-18-miliardi-di-dollari-per-combattere-aids-tubercolosi-e-malaria/ 2022-05-24T12:25:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibsa-acquisisce-la-britannica-pharmasure/ 2022-05-24T12:42:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-arriva-il-nuovo-sistema-di-smart-cgm-guardian-4-system/ 2022-05-24T13:15:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/metaverso-aspetti-positivi-e-negativi-per-i-pazienti/ 2022-05-25T09:03:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-testa-potenziali-vaccini-contro-il-vaiolo-delle-scimmie/ 2022-05-25T09:16:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-vaccines-a-siena-levento-embl-in-italy/ 2022-05-25T10:33:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-ghebreyesus-rieletto-dg-dellorganizzazione-mondiale-della-sanita/ 2022-05-25T10:49:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nel-mm-aumenta-sopravvivenza-mediana-con-isatuximab-in-combinazione-con-inibitori-del-proteasoma/ 2022-05-25T12:30:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-farmaci-nonprofit-price-ai-paesi-a-basso-reddito/ 2022-05-25T13:33:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-pierluigi-petrone-eletto-presidente-del-comitato-nazionale-piccola-industria-di-farmindustria-2022-2024/ 2022-05-25T15:16:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-in-vigore-il-nuovo-regolamento-sui-dispositivi-diagnostici-in-vitro/ 2022-05-26T15:25:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-sviluppa-test-per-rilevare-il-virus-del-vaiolo-delle-scimmie/ 2022-05-26T15:49:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/b-braun-cento-anni-in-italia-per-celebrarli-un-progetto-di-riforestazione/ 2022-05-26T12:04:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/test-diagnostici-sempre-piu-alleati-delle-terapie/ 2022-05-26T12:56:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-investe-nella-produzione-in-usa/ 2022-05-26T14:23:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-una-guida-per-lo-sviluppo-globale-di-farmaci-antimicrobici/ 2022-05-27T09:32:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adv-pharma-vince-ancora-la-tv/ 2022-05-27T10:41:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-e-legend-biotech-nuovi-dati-su-terapia-car-t-carvykti-nel-mieloma-multiplo/ 2022-05-27T12:29:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-nuova-sede-regionale-a-dubai/ 2022-05-27T12:55:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/world-digestive-health-day-limpegno-di-alfasigma/ 2022-05-27T13:27:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cumulus-neurosciences-al-via-studi-clinici-su-panel-di-biomarker-per-malattie-neurodegenerative/ 2022-05-27T14:06:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-ok-fda-a-ivosidenib-in-combinazione-con-azacitidina-nella-lma-con-mutazione-idh1/ 2022-05-30T13:06:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fattore-j-presentato-in-consiglio-regionale-della-lombardia-il-primo-manifesto-della-salute-ideato-dai-giovani/ 2022-05-30T14:07:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/equita-di-genere-solo-2-dg-su-10-nelle-strutture-sanitarie-sono-donne-i-dati-dellosservatorio-sullequita-di-genere-della-leadership-nel-settore-sanitario/ 2022-05-30T14:48:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-al-congresso-era-2022-tre-studi-su-daprodustat/ 2022-05-30T15:02:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-una-regata-velica-per-i-pazienti-con-trombocitopenia-immune/ 2022-05-30T15:55:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cart-cina-supera-paesi-occidentali-nella-pipeline-di-ricerca/ 2022-05-30T16:48:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asco-2022-attesa-per-i-risultati-di-tre-farmaci/ 2022-05-31T09:10:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-annuncia-lacquisizione-di-affinivax/ 2022-05-31T17:02:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/unione-europea-verso-accordo-comune-per-acquisto-vaccini-e-antivirali-contro-il-vaiolo-delle-scimmie/ 2022-05-31T10:02:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-oncologi-aumentano-lanci-e-sperimentazioni/ 2022-05-31T16:59:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-fda-a-risdiplam-nei-bambini-di-eta-inferiore-ai-due-mesi-con-sma/ 2022-05-31T14:12:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-aifa-a-combo-atezolizumab-bevacizumab-negli-adulti-con-hcc-avanzato-o-non-resecabile-non-sottoposti-a-precedente-terapia-sistemica/ 2022-06-01T09:41:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-accordo-con-fondo-biotech-israeliano-per-produrre-small-molecules/ 2022-06-01T12:59:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-iniziativa-globale-per-migliorare-laccesso-ai-biosimilari/ 2022-06-01T13:19:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-italia-valentino-confalone-e-il-nuovo-country-president/ 2022-06-01T16:29:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antitumorali-gli-inibitori-pd1-fanno-crescere-la-spesa/ 2022-06-01T14:18:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pnrr-e-scompenso-cardiaco-potenziali-benefici-ma-se-si-sbaglia-si-rischia-un-aumento-della-mortalita-lallarme-a-camerae-sanitatis/ 2022-06-01T14:43:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-centro-d-coordinamento-nazionale-comitati-etici-pubblica-schemi-di-contratto-per-la-sperimentazione-clinica-sui-medicinali-e-per-le-indagini-cliniche-su-dispositivi-medici/ 2022-06-01T16:29:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-nel-tumore-al-seno-metastatico-her2-low-trastuzumab-deruxtecan-riduce-il-rischio-di-progressione-della-malattia-e-di-morte-del-50-rispetto-alla-chemioterapia/ 2022-06-06T09:36:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk-la-sanita-e-migliore-se-ce-empowerment-ed-engagement-dei-pazienti/ 2022-06-06T10:09:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/health-serie-oncologia-di-precisione-la-rivoluzione-possibile/ 2022-06-06T10:20:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/retail-farmaceutico-neoapotek-finanziamento-da-100mln-di-euro-per-arrivare-entro-fine-anno-a-200-farmacie/ 2022-06-06T13:26:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-acquisisce-da-sanofi-i-diritti-sullantitumorale-libtayo-da-sanofi/ 2022-06-06T12:47:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-rafforza-il-portfolio-oncologico-con-turning-point/ 2022-06-06T13:30:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-il-vaccino-contro-morbillo-parotite-e-rosolia-ottiene-lapprovazione-della/ 2022-06-07T09:09:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-combo-tafinlar-e-mekinist-efficace-in-tumore-del-cervello-delleta-infantile/ 2022-06-07T09:38:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-disponibile-in-italia-il-primo-farmaco-spray-nasale-per-il-trattamento-della-depressione-maggiore/ 2022-06-07T10:34:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-il-momento-dei-contenuti-audio/ 2022-06-07T13:08:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-con-ixekizumab-il-60-dei-pazienti-al-sicuro-da-spondiloartrite-anche-al-terzo-anno-di-cura/ 2022-06-07T15:06:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-biologics-accordo-di-produzione-a-contratto-da-81-mln-di-dollari-con-novartis/ 2022-06-08T15:13:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-accordo-con-alectos-therapeutic-per-farmaco-contro-il-parkinson/ 2022-06-08T09:32:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-studio-israeliano-paxlovid-riduce-il-rischio-di-covid-negli-anziani-indipendentemente-dalla-situazione-vaccinale/ 2022-06-08T09:56:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-fda-a-dupixent-per-eczema-bambini-dai-6-mesi-a-5-anni/ 2022-06-08T12:40:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/health-serie-oncologia-di-precisione-garantire-accesso-e-informazione-per-tutti-i-pazienti-eleggibili/ 2022-06-08T14:56:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-il-nuovo-booster-produce-una-risposta-piu-forte-contro-omicron/ 2022-06-09T09:02:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fidia-farmaceutici-crescita-a-doppia-cifra-ebitda-superiore-al-20-sul-fatturato/ 2022-06-09T09:38:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-ce-ad-atezolizumab-come-trattamento-adiuvante-nel-nsclc-ad-alto-rischio-di-recidiva/ 2022-06-09T10:17:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/national-summit-per-aiic-non-basta-spendere-miliardi-in-macchinari-per-avere-un-ssn-moderno-e-tecnologico/ 2022-06-09T12:25:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-al-via-la-quarta-edizione-del-premio-letterario-angelo-zanibelli-la-parola-che-cura/ 2022-06-09T13:35:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-evusheld-riduce-il-rischio-di-covid19-grave/ 2022-06-09T13:56:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/veeva-lancia-veeva-vault-study-training/ 2022-06-10T16:20:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-lotta-allo-stigma-hiv-in-italia-ecco-quattro-ricerche/ 2022-06-10T15:09:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-due-giorni-con-le-associazioni-per-disegnare-un-ssn-a-misura-di-paziente/ 2022-06-10T11:01:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-risultati-positivi-per-il-vaccino-contro-il-virus-respiratorio-sinciziale-dallo-studio-aresvi-006/ 2022-06-10T12:30:38+00:00 monthly 0.2